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Propensity scoring is often utilized to overcome the challenges posed by covariate
imbalance to make causal inferences within observational studies. While methods for
utilizing propensity scoring in a binary treatment case are well studied and established,
generalizations to multiple unordered (multinomial) and continuous treatments are more
complicated. In Aim 1, we developed and tested a novel multinomial treatment propensity
score method, the GPS-CDF method, which derives a single scalar balancing score that can
match and stratify subjects. Simulation results showed superior performance of the new
methodology compared to standard multinomial propensity score methods. The proposed
GPS-CDF method was also applied to an electronic health records study to determine the
causal relationship between vasopressor choice and mortality in patients with non-traumatic
aneurysmal subarachnoid hemorrhage (SAH). The GPS-CDF method indicated that
phenylephrine may be the superior vasopressor choice for patients that present with nontraumatic SAH. We further applied the GPS-CDF method to the Emergency Truncal
Hemorrhage Control Study to determine whether emerging hemorrhage control interventions
influence patient mortality. Based on the GPS-CDF method, patients receiving resuscitative

endovascular balloon occlusion of the aorta (REBOA) had similar morality as patients who
received Laparotomy. In Aim 2, we extended the GPS-CDF method to the continuous
treatment setting and further introduced the npGPS-CDF method. Both novel methods use
empirical cumulative distribution functions (CDF) in order to stratify subjects based on
pretreatment confounders to produce causal estimates. A detailed simulation study showed
superiority of the novel methods based on the empirical CDF when compared to standard
weighting techniques. The proposed methods were applied to the “Mexican American
Tobacco use in Children” (MATCh) study and found a significant association between
exposure to smoking imagery in movies and smoking initiation among Mexican-American
adolescents. Finally in Aim 3, we developed an R package for researchers to implement the
proposed GPS-CDF method in practice. Overall this research provides investigators with new
options for implementing multinomial and continuous treatment propensity scoring.
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CHAPTER I

Background

1.1 Introduction
While randomized experiments are considered the gold standard when evaluating
causal treatment effects, it is sometimes difficult to implement this design due to potential
logistical and ethical issues, high cost, and low generalizability to a larger population.
Instead, researchers often use observational studies to measure treatment effects. Currently,
data from large observational studies including national surveys, electronic health records
(EHR), and genome wide association studies (GWAS) are becoming publicly available.
Although there is an influx in the amount of data available, treatment assignment in
observational studies is not randomly assigned. Thus subjects receiving a treatment may
differ from subjects not receiving a treatment based on one or more covariates. This covariate
imbalance between treatment groups makes causal inference more challenging.
Propensity scoring is often utilized to overcome the challenges posed by covariate
imbalances to make causal inference. In a binary treatment case, which includes one
treatment and one control group, the propensity score is the probability of receiving the
treatment conditional on a given set of observed covariates (Rosenbaum and Rubin, 1983).
This probability (commonly called the propensity score) can be calculated using standard
regression techniques (typically logistic regression) with the treatment (𝑍𝑍) being considered
the outcome and the covariates (𝑿𝑿) the predictors. Treatment and control subjects with
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similar estimated values for their propensity scores will have, on average, similar sets of
covariate vectors (Greene, 2017). Since it can be used to remove covariate imbalance
between treatment groups, the propensity score is known as a balancing score (Greene,
2017).
In order for the propensity score to be used to conduct causal inference in
observational studies, a few assumptions need to be met, namely: consistency,
exchangeability, positivity, and no misspecification of the propensity score model (Austin
and Stuart, 2015). Consistency implies that a subject’s potential outcome under the treatment
they received is equal to the subject’s observed outcome. Exchangeability assumes all true
confounders for treatment assignment and the relationship with the outcome are observed and
measured. Although not testable, conducting propensity scoring without measuring all
possible variables that influence treatment assignment and the outcome can result in biased
estimates of the treatment effect. The positivity assumption states that all subjects have a
non-zero (positive) probability of receiving each treatment. This assumption can be tested by
confirming overlap of histograms or boxplots of each subject’s propensity score stratified by
treatment group. Finally, misspecification of the propensity score model, although formally
untestable, seeks to find the ‘true’ propensity score to balance covariates between treatment
groups. In practice, there are many balancing scores that can remove covariate imbalance
between groups (Rosenbaum and Rubin, 1983), so this assumption is considered met if
covariate balance is achieved between treatment groups (Austin and Stuart, 2015).
When conducting causal inference using propensity scoring, researchers are interested
in two possible summary measures of the treatment effect, the average treatment effect
(ATE) or the average treatment effect among the treated (ATT). ATE is of interest for
2

comparisons of the mean outcome when the entire population is eligible for all treatments
(McCaffrey et al., 2013). In a binary treatment setting with one treatment and one control
group, ATE is the effect of giving the treatment to the entire population instead of giving the
control to the entire population. ATE is calculated by taking the expectation across the entire
population and is given by:
𝐴𝐴𝐴𝐴𝐸𝐸𝑘𝑘,𝑘𝑘′ = 𝐸𝐸 [𝑌𝑌(𝑘𝑘) − 𝑌𝑌 (𝑘𝑘 ′ )] = 𝐸𝐸 [𝑌𝑌(𝑘𝑘)] − 𝐸𝐸[𝑌𝑌(𝑘𝑘 ′ )]

(1.1)

where 𝑌𝑌 is the outcome for the comparison of treatment 𝑘𝑘 and treatment 𝑘𝑘′. ATT is of

interest when comparing the effectiveness of a particular treatment relative to the alternatives
available to the population of interest (McCaffrey et al., 2013). Thus in the binary treatment
setting, ATT finds the effect of the treatment only on those who actually received the
treatment. The formal definition of ATT is given by:
𝐴𝐴𝐴𝐴𝑇𝑇𝑘𝑘,𝑘𝑘′ = 𝐸𝐸 [𝑌𝑌(𝑘𝑘′) | 𝑍𝑍 = 𝑘𝑘] − 𝐸𝐸[𝑌𝑌(𝑘𝑘) | 𝑍𝑍 = 𝑘𝑘]

(1.2)

where 𝑌𝑌 is the outcome and 𝑍𝑍 is the treatment of interest.

It has been shown that the difference between treatment and control subjects at each

value of a balancing score is an unbiased unit-level estimate of the ATE or ATT if treatment
assignment between subjects is independent given a set of covariates (Rosenbaum and Rubin,
1983). That is to say, within matched pairs or strata of a balancing score, treatment
assignment is independent of observed covariates. By using a balancing score for matching,
stratification, or adjustment, the outcome analysis will produce unbiased estimates of ATE or
ATT. Thus by using the propensity score in the final outcome analysis, researchers are able
to make causal inferences with observational data.

3

Current Methods for Multinomial Treatments
While methods for utilizing propensity scoring in a binary treatment case are well
studied and established, generalizations to multiple unordered (multinomial) treatments are
more complicated. Intuitively in this treatment setting, analyses among multinomial
treatments can be broken down into a series of binary comparisons (Lechner, 2001; 2002).
For example, in an experimental setting with 3 treatment arms (A, B, and C), analyses can be
conducted within treatment pairs (A,B), (A,C), and (B,C). This decomposition facilitates the
utilization of binary propensity score methods on each of the pairwise treatment
comparisons. Alternatively, using common reference matching, propensity scores can be
used to match subjects, for example, within the pairs (A,B) and (A,C). Then using these two
matched samples, a final cohort of 1:1:1 matched triplets can be created (Rassen et al., 2011).
This final cohort would include subjects who received treatment A that were matched to both
a subject receiving treatment B and a subject receiving treatment C (Rassen et al., 2011).
Although these two approaches enable the implementation of standard binary propensity
scoring, the results are compromised by limited external validity. Furthermore, these
approaches are only able to estimate ATT, which is not always the estimate of interest. This
makes it difficult to identify a superior treatment for the general population which is a
common goal in many analyses (Lopez and Gutman, 2017).

1.1.1 Generalized Propensity Score
Instead of decomposing the multiple treatment setting into binary treatment
comparisons, the generalized propensity score (GPS) can be used to extend the theory of
4

causal inference from a binary treatment setting to a multiple treatment setting (Joffe and
Rosenbaum, 1999; Imbens, 2000; Imai and Van Dyk, 2004). The GPS is defined as the
probability of receiving one of 𝐾𝐾 treatments conditional on a given set of observed covariates
(Imbens, 2000). Unlike the binary treatment case where the propensity score is a single value
representing the probability a subject was treated, the GPS is a vector, of length 𝐾𝐾,

representing the probabilities of a subject being treated under each of the 𝐾𝐾 conditions.

Commonly used methods for propensity scoring in the presence of multinomial

treatments have relied on the GPS vector that is produced from some type of multinomial
regression model, e.g.,
𝑃𝑃𝑃𝑃(𝑍𝑍𝑖𝑖 = 𝑘𝑘)
� = 𝜃𝜃𝑘𝑘 + 𝑥𝑥𝑖𝑖′ 𝛽𝛽𝑘𝑘
log �
𝑃𝑃𝑃𝑃(𝑍𝑍𝑖𝑖 = 𝐾𝐾 )

(1.3)

where 𝜃𝜃𝑘𝑘 is a constant, 𝛽𝛽𝑘𝑘 is a vector of regression coefficients, 𝑍𝑍 is the treatment received,
and 𝐾𝐾 if the total number of treatments, for 𝑘𝑘 = {1,2, … , 𝐾𝐾 − 1}. In this nominal case,

treatments do not follow any set order, so there is no defined relationship between the various
treatment assignments.

1.1.2 Distance Metrics
Distance metrics can be used to match subjects with similar GPS vector distributions.
Aitchison distance, a compositional data analysis tool, has been proposed as one way to
match subjects based on the relative distance of their GPS vectors (Seya and Yoshida, 2017).
Additionally, Rassen et al. developed the ‘within-trio’ matching algorithm that finds a triplet
of patients, with different treatments, while minimizing the within-trio distance (Rassen et
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al., 2013). Although these procedures successfully match subjects, there are potential draw
backs. First, they cannot be used to derive ATE, in the case of Aitchison distance, and
second, they cannot be used for more than three treatments, in the case of ‘within-trio’
matching. Mahalanobi’s distance, a commonly used multivariate distance metric, can also be
used to match subjects (Rubin, 1979; Zhao, 2004). Instead of using the GPS vector,
Mahalanobi’s distance matches subjects with similar covariate distributions. While
Mahalanobi’s distance has been shown to be effective for matching in analyses involving a
limited number of covariates (Rubin, 1979; Zhao, 2004), it does not perform well when there
are more than 8 covariates or when the covariates are not normally distributed (for example if
they are non-continuous (Gu and Rosenbaum, 1993; Stuart, 2010)). Additionally, distance
metrics need to be modified to enable matching across different treatments since subjects
within a treatment group will more likely have similar distances.

1.1.3 Clustering Techniques
Extensions to the above include clustering techniques as a possible method to group
subjects with similar GPS vectors. Tu et al. demonstrated how four popular clustering
techniques could be used to group subjects with similar observed covariate distributions
based on a transformation of the GPS vector (Tu et al., 2013). Ultimately, Tu et al. showed
that k-Means clustering (KMC), which minimizes the sum of squares between a subject in a
cluster and the centroid of that cluster, provides the best covariate similarity between subjects
in different treatment groups (Tu et al., 2013; Lopez and Gutman, 2017). Lopez et al. further
extended these methods by combining KMC and 1:1 matching to create a matched analysis
cohort (Lopez and Gutman, 2017). Lopez et al. first utilized KMC to place subjects into
6

clusters with similar values for one or more components of the GPS vector, and subsequently
matched subjects (within each sub-cluster) using standard propensity score techniques
(Lopez and Gutman, 2017). Matching within sub-clusters ensures that subjects will have
matched values for one component of the GPS vector and similar values for the other
components. However, with clustering, there exists the possibility of obtaining clusters
without representation from every possible treatment group (Lopez and Gutman, 2017).
Moreover, after running KMC, Lopez et al. limits matching to within each cluster which may
lead to some possible matches not being considered by the method (Lopez and Gutman,
2017). Furthermore, as clustering techniques utilize distance metrics in their algorithms, they
are subject to the same limitations as Mahalanobi’s distance when used to balance covariates.

1.1.4 Machine Learning Methods
Although multinomial regression is the most commonly used method for estimating
the GPS vector, other techniques may be considered. Notably, non-parametric machine
learning methods of estimating the GPS vector, such as the generalized boosted model
(GBM), recursive partitioning, and neural nets have been proposed (McCaffrey et al., 2004;
Setoguchi et al., 2008; McCaffrey et al., 2013; Burgette et al., 2017). Although not wellstudied, GBM and other tree-based methods could provide a few notable benefits over
parametric regression. For example, variable selection including the decision to include
higher order or interaction terms in the model occurs automatically, unlike with parametric
models. This is of particular importance when working with ‘big data’ (i.e. EHR, GWAS,
etc.) as there are a large number of covariates available to be selected for the GPS
(McCaffrey et al., 2013). Further, the iterative estimation procedure used by GBM, which fits
7

regression trees that maximize log likelihood in order to produce a piecewise constant model
that perfectly fits the data, can easily be fine-tuned to provide the propensity score model
with the best balance between treatment groups (McCaffrey et al., 2013). After estimating the
GPS vector, inverse probability weighting (where the weight is the inverse propensity of the
treatment an individual actually received (Imbens, 2000; Feng et al., 2012; McCaffrey et al.,
2013; Burgette et al., 2017)) can be applied directly to the outcome (Feng et al., 2012) or be
utilized within weighted regression models (McCaffrey et al., 2013; Burgette et al., 2017) to
estimate ATEs. Additionally, when the weights derived by multiplying the inverse
probability weight by the probability an individual received the target treatment, weighted
regression models can estimate ATTs (McCaffrey et al., 2013; Burgette et al., 2017).
However, while it might initially appear that non-parametric methods of estimating
the GPS vector could be immediately adapted to the multiple treatment setting in conjunction
with inverse probability weighting (IPW), this approach is limiting for several notable
reasons. First, because non-parametric methods only estimate a GPS vector, matching and
stratification in the outcome analysis cannot be performed since no obvious scalar balancing
score can currently be produced from the resultant vector. Thus machine learning algorithms
are limited to IPW to derive treatment effects; however, IPW may produce unreliable
outcome estimates with large sample variances due to extreme weights (Busso et al., 2014;
Lopez and Gutman, 2017; Li et al., 2018). Alternative weighting methods have been
proposed that are not as susceptible to these extremes (Hirano and Imbens, 2001; Imai and
Ratkovic, 2014; Li et al., 2018), but since weighting directly uses the scalar estimated
propensity score in determining the effect of treatment (Austin et al., 2007; Rubin, 2004), as
Rubin (Rubin, 2004) suggests, this results in the greatest sensitivity to misspecification of the
8

propensity score. Furthermore, the use of GBM may suffer from issues of power when some
(but not complete) structure in the data can be assumed. Finally, the black box nature of
nonparametric approaches prevent the user from being able to discern how the model
specifically utilizes each variable in producing the propensity scores (Ridgeway et al., 2016).
These limitations have impeded the use of nonparametric methods in propensity scoring over
the last decade, despite their promise.

1.1.5 Stratification, Matching, Adjustment
Even though a function that maps the GPS vector to a scalar balancing score does not
currently exist, methods for covariate balancing using stratification, matching, and
adjustment based on the GPS vector have been studied in the multiple treatment setting.
Stratification techniques using the GPS vector were first described by Zanutto et al. (Zanutto
et al., 2005) and further extended by Huang et al (Huang et al., 2005). Huang et al. showed
that stratification of subjects by propensity scores at each treatment level, in combination
with weighted averages, can produce estimates of the average potential outcome (Huang et
al., 2005). Yang et al. utilized a similar stratification and weighting method for covariate
balancing, but further extended the method to match subjects in order to produce causal
treatment effects (Yang et al., 2016). A similar matching procedure was also used by Lechner
(Lechner, 2001). Additionally, Feng et al. was able to estimate ATEs by using generalized
linear models to assess the relationship between outcomes and the GPS vector; then by using
this model, estimate the expected outcome of a subject under a certain treatment given the
GPS (Feng et al., 2012).

9

Though these procedures are more relatable to the methods available in standard
binary propensity scoring, a cornerstone of these approaches is the estimation of average
potential outcomes that are performed separately for each treatment level. This does simplify
the inherent problems that arise when creating balance among multiple treatment groups, but
since these approaches are only concentrating on one element of the GPS vector instead of
the full GPS vector (Greene, 2017), they might suffer from a loss of information and thus not
create the best possible covariate balance. Additionally, the methods proposed by Huang et
al. (Huang et al., 2005) and Yang et al. (Yang et al., 2016) suffer from their inability to adjust
for covariates in the outcome model and further lack the flexibility to be applied to complex
analyses.

Current Methods for Continuous Treatments
Although methods for propensity scoring in both binary and multiple treatment
settings have been well studied (Rosenbaum and Rubin, 1983, 1984, 1985; Joffe and
Rosenbaum, 1999; Imbens, 2000; Imai and Van Dyk, 2004), there has been less research
devoted to propensity score methods for continuous treatments. In practice when presented
with continuous treatments, researchers often dichotomize or categorize the treatment in
order to utilize standard and well established propensity score techniques (e.g. Chertow et al.,
2004; Davidson et al., 2006; Donohue and Ho, 2007; Flores-Lagunes, Gonzalez, and
Neumann, 2007; Harder et al., 2008; Boyd et al., 2010; Nielsen et al., 2011; Greene, 2017).
Although propensity score methods are correctly applied in these settings, categorization of a
continuous treatment may lead to loss of information and power during the outcome analysis
(Royston et al., 2006; Zhu et al., 2015; Fong et al., 2018).
10

1.1.6 Maximum Likelihood Estimation
Instead of decomposing the continuous treatment setting into binary or categorical
treatment comparisons, maximum likelihood estimates (MLE) derived from linear models
have been proposed to estimate the generalized propensity score (GPS) (Robins et al., 2000;
Imai and Van Dyk, 2004; Hirano and Imbens, 2004). In the continuous treatment framework,
𝑟𝑟(𝑡𝑡, 𝑥𝑥 ), the conditional density of the treatment given the covariates, is defined as
𝑟𝑟(𝑡𝑡, 𝑥𝑥 ) = 𝑓𝑓𝑇𝑇|𝑋𝑋 (𝑡𝑡|𝑥𝑥)

(1.4)

where 𝑇𝑇 represents the continuous treatment and 𝑿𝑿 the covariates of interest (Hirano and

Imbens, 2004). Thus the GPS for continuous treatments is defined as 𝑅𝑅 = 𝑟𝑟(𝑇𝑇, 𝑋𝑋) (Hirano

and Imbens, 2004). In practice, this GPS can be estimated by fitting a linear regression model
of the form
𝑇𝑇 = 𝜷𝜷𝜷𝜷 + 𝜀𝜀

(1.5)

where 𝜀𝜀 ~ 𝑁𝑁(0, 𝜎𝜎 2 ). Then the GPS is estimated as
𝑅𝑅�𝚤𝚤 =

1

√2𝜋𝜋𝜎𝜎� 2

exp �−

1
2
�𝑇𝑇𝑖𝑖 − 𝑇𝑇�𝑖𝑖 � �
2
2𝜎𝜎�

(1.6)

for the 𝑖𝑖 𝑡𝑡ℎ individual (Hirano and Imbens, 2004). Although 𝑅𝑅�𝚤𝚤 , applied directly in regression
� 𝑿𝑿𝒊𝒊 , utilized for matching or
adjustment (Hirano and Imbens, 2004), or the scalar value, 𝜷𝜷
stratification (Imai and Van Dyk, 2004), can produce causal estimates, using the GPS in

weighted outcome analyses has been given more attention recently (Robins et al., 2000; Zhu
et al., 2015; Schuler et al., 2016; Fong et al., 2018; Austin, 2018a; Austin, 2018b).
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Robins et al. proposed using the GPS to produce causal estimates by implementing
inverse probability weighting (IPW) (Robins et al., 2000). Briefly, IPW seeks to weight
subjects with dissimilar covariate distributions higher than subjects with similar covariate
profiles within the same treatment. That is to say, IPW gives higher weight to subjects, under
a certain treatment, who have similar covariate distributions as subjects who received a
different treatment. In the calculation of 𝑅𝑅�𝚤𝚤 , subjects with unexpected covariate distributions

will have large estimates for 𝑇𝑇𝑖𝑖 − 𝑇𝑇�𝑖𝑖 and conversely have small values for 𝑅𝑅�𝚤𝚤 . Thus the IPW,

given by

𝑤𝑤𝑖𝑖 =

1
𝑅𝑅�𝚤𝚤

(1.7)

will be higher, effectively giving more weight to subjects that have unexpected covariate
distributions based on their treatment assignment.
Although weights using the GPS can be applied directly in the form given above,
Robins et al. warn that 𝑤𝑤𝑖𝑖 has infinite variance and a stabilizing factor should be applied to

𝑤𝑤𝑖𝑖 to be used in practice (Robins et al., 2000). This stabilizing factor, 𝑊𝑊 (𝑇𝑇𝑖𝑖 ), is given by the

marginal density of 𝑇𝑇 and can be estimated by first fitting an intercept only model of the

form

𝑇𝑇 = 𝛽𝛽0 + 𝜀𝜀

(1.8)

2
�. Then the stabilizing factor is estimated as
where 𝜀𝜀 ~ 𝑁𝑁�0, 𝜎𝜎𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠

� (𝑇𝑇𝑖𝑖 ) =
𝑊𝑊

1

2
�2𝜋𝜋𝜎𝜎�𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠

exp �−
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1

2
2𝜎𝜎�𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠

(𝑇𝑇𝑖𝑖 − 𝜇𝜇̂ )2 �

(1.9)

where 𝜇𝜇̂ is the mean treatment value of the sample (Austin, 2018b). Thus the final estimated
stabilized IPW is given by

𝑠𝑠𝑠𝑠𝑖𝑖 =

� (𝑇𝑇𝑖𝑖 )
𝑊𝑊
.
𝑅𝑅�𝚤𝚤

(1.10)

Although the calculation of these weights is straightforward, the MLE method
detailed above relies heavily on correctly specifying the linear treatment model. If the model
is not correctly specified or the model assumptions are not met (i.e. normality assumptions),
the MLE method can produce extreme weights that can lead to severely biased outcome
estimates (Fong et al., 2018). Therefore, methods that operate outside of this MLE
framework may produce better weights, leading to more covariate balance, and less biased
estimates of the outcome.

1.1.7 Generalized Boosted Model
While Flores et al. estimates the GPS through generalized linear models (Flores et al.,
2007), non-parametric methods of estimating the GPS vector, such as kernel methods,
penalized spline models, and the generalized boosted model (GBM), can provide more
accurate estimates of the GPS compared to parametric regression (Bia et al., 2014; Zhu et al.,
2015). Instead of estimating a linear model for treatment on 𝑿𝑿, like in a parametric setting,
GBM fits a more general model of the form

𝑇𝑇 = 𝑚𝑚(𝑿𝑿) + 𝜀𝜀
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(1.11)

where 𝜀𝜀 ~ 𝑁𝑁(0, 𝜎𝜎 2 ) and 𝑚𝑚(𝑿𝑿) is the mean function of 𝑇𝑇 given 𝑿𝑿 (Zhu et al., 2015). This

mean function can be estimated using a machine learning algorithm, boosting, that additively
fits regression trees until the model is sufficiently flexible to fit the data (McCaffrey et al.,
2013; Zhu et al., 2015). Boosting automatically selects important covariates, nonlinear terms,
and interaction terms to accurately estimate the mean function thus providing better estimates
of the GPS (McCaffrey et al., 2013; Zhu et al., 2015). With the mean function derived,
stabilized IPW can be calculated and implemented just like in the MLE weighting procedure.
While it seems that GBM provides better estimates of the GPS, thereby providing
less biased outcome estimates, there are still draw backs that limit this method. First, the
method does not give users the ability to force variables into the final treatment model. The
black box nature of GBM prevents the user from knowing how the model specifically utilizes
each variable in producing the final propensity scores (Ridgeway et al., 2016). Additionally,
although GBM has been shown to outperform MLE in simulation, covariate balance after
GBM weighting can still remain poor leading to unstable estimates, worse than if no weights
had been applied at all (Fong et al., 2018). Finally, while GBM does attempt to optimize
balance, the only way to improve balance is by increasing the number of regression trees
used by the method which may still not provide adequate control over sample imbalance
(Fong et al., 2018).

1.1.8 Covariate Balancing Generalized Propensity Score
Recently, work has been done to extend the Covariate Balancing Propensity Score,
which models treatment assignment while optimizing covariate balance, to the continuous
treatment setting (Imai and Ratkovic, 2014; Fong et al., 2018). This new method, termed
14

Covariate Balancing Generalized Propensity Score (CBGPS), uses moment conditions to
derive IPW such that the weighted correlation between 𝑿𝑿 and 𝑇𝑇 is minimized (Fong et al.,

2018). While the CBGPS method has a parametric approach that follows closely to the MLE
method, it also has a nonparametric extension that places no parametric restrictions on the
GPS nor on the marginal distribution of the treatment (Fong et al., 2018). This
nonparametric Covariate Balancing Generalized Propensity Score (npCBGPS) gives
researchers a method to directly derive weights without giving a functional form to the
propensity scores (Fong et al., 2018).
Even though the CBGPS offers a method to optimize covariate balance while
estimating the GPS, it is still not without limitations. Specifically, in simulation studies, it has
been shown that GBM produces less biased outcome estimates compared to CBGPS and
npCBGPS when sample sizes are large (~1,000) (Fong et al., 2018). Additionally, since the
nonparametric extension, npCBGPS, is based on an empirical likelihood approach, there is
no guarantee that the optimization procedures find the global optimum (Fong et al., 2018).
Furthermore, when the number of covariates is large or if 𝑿𝑿 strongly predicts 𝑇𝑇, the

npCBGPS can fail to find a solution leaving the researcher to sacrifice covariate balance to
derive weights (Fong et al., 2018).
Although there are many methods that seek to create balanced data for multiple and
continuous treatments within observational studies, these methods are complex, possibly
difficult to implement in practice, and do not have the same flexibility as a scalar balancing
score used in typical binary propensity score methods. The goal of this work will be to
develop and test new methodology to better conduct propensity scoring for more complicated
treatment settings.
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1.2 Public Health Significance
Randomized control trials are considered the gold standard when conducting
research. The reason for this is due to the randomization that can be performed by researchers
at the start of the study. Before the initiation of the study, researchers have the ability to
balance covariates among the treatment groups by randomly assigning subjects to the groups.
This randomization effectively creates treatment groups, with no systematic differences, that,
on average, are identical in terms of their covariates. At the end of the study, when
conducting the outcome analysis, any differences in the outcome can be attributed directly to
the treatment, and not due to any covariate bias, as randomization successfully produces
covariate balance between the treatment groups. Thus due to the randomization performed at
the start of the study, causal inference in randomized control trials is made possible as there
is covariate balance between the treatment groups. Although randomized experiments allow
for direct causal inference between a treatment and an outcome, their utilization is not
practical under many scenarios.
Instead, researchers can implement observation studies when randomized
experiments are not feasible. That is, when the disease of interest is rare, subjects cannot be
randomized to exposure groups do to ethical issues, the study will be too costly, etc. Thus,
observation studies are highly utilized in public health analyses. While these study designs
facilitate research that otherwise may not be feasible to conduct, investigators using
observational study designs relinquish the ability to randomize subjects into treatment groups
as their data is observational. Thus at the end of an observational study, there is no longer
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covariate balance between the treatment groups. As a result, observational studies restrict an
investigator’s capacity to make causal inferences without utilizing complex statistical tools.
To create covariate balance between the treatment groups within observational
studies, researchers often use propensity scoring. The underlying theory is that subjects with
the same values for their propensity scores will have, on average, similar covariate profiles.
Thus by using the propensity score in the outcome analysis, researchers are able to create
covariate balance and produce causal estimates with observational studies.
Existing research in the area of propensity score methodology is limited outside
binary treatment comparisons. Additionally, as data from large observational studies
becomes more readily available, new propensity score methods are needed for these data
types. Continuation of research into novel methods of propensity scoring is needed to ensure
causal estimates can be made under all treatment scenarios and data types.

1.3 Specific Aims
1.3.1 To develop a novel method of propensity score analysis for multinomial treatments
As detailed above, current multinomial methods do not utilize the full GPS vector to
match, stratify, or weight subjects. Although GBM, the most commonly used machine
learning method for propensity scoring in multiple treatment scenarios, does have the ability
to accurately derive the GPS vector, outcome analyses are limited by implementation of the
GPS vector though IPW. Using a single value of the GPS may result in inaccurate outcome
estimates. Therefore, developing a method that has the same flexibility as the scalar value
used in binary treatment settings that can encapsulate the full GPS vector would be a useful
addition to current propensity score literature. The proposed method can be used with all
17

types of propensity score models (parametric and non-parametric) and will adapt machine
learning methods for the use in regular as well as complex observational data types, such that
both matching and stratification are supported.

1.3.2 To develop a novel method of propensity score analysis for continuous treatments
In the continuous treatment setting, the GPS is not estimable through logistic
regression models, as is common with binary and multiple treatments. Instead, methods for
creating balanced data for the continuous treatment setting within observational studies have
relied heavily on weighting procedures. Although methods have been proposed that operate
outside of a parametric setting to derive weights, all weighting methods may produce
unreliable outcome estimates due to extreme weights. Thus methods that do not utilize
weighting nor rely on parametric assumptions may produce more reliable outcome estimates.
Specifically, a method that can accurately stratify subjects based on a desired set of
covariates would be a valuable tool for researchers.

1.3.3 To develop an R package to implement multiple treatments propensity scoring
methods
The utility of new a propensity score method is directly related to the ease by which it
can be used by researchers. Methods often require significant data manipulation, nuanced
selection procedures, and complex algorithms to be used in practice. Thus having a standard
R package that can be downloaded and easily adapted for various research projects will
exponentially increase the notoriety of new propensity score methods and help facilitate more
robust propensity score analyses by researchers.
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Abstract
The generalized propensity score (GPS), a vector whose elements represent the
probabilities a subject was assigned each treatment, is used to extend work in binary
treatment propensity scoring to the multiple treatment setting. Currently, methods for
conducting multiple treatment propensity scoring in the presence of high-dimensional
covariate spaces that result from ‘big data’ are lacking – the most prominent method relies on
inverse probability treatment weighting (IPTW). However, IPTW only utilizes one element
of the GPS vector and can lead to a loss of information and inadequate covariate balance in
the presence of multiple treatment groups. The above limitations motivate the development
of a novel propensity score method that uses the entire GPS vector to establish a scalar
balancing score that when adjusted for, achieves covariate balance in the presence of
potentially high-dimensional covariates. Specifically, the generalized propensity score
cumulative distribution function (GPS-CDF) method is introduced. A one-parameter power
function fits the CDF of the GPS vector and a resulting scalar balancing score is used for
matching and/or stratification. Simulation results show superior performance of the new
method compared to IPTW both in achieving covariate balance and estimating average
treatment effects in the presence of multiple treatments. The proposed approach is applied to
a study derived from electronic medical records to determine the causal relationship between
three different vasopressors and mortality in patients with non-traumatic aneurysmal
subarachnoid hemorrhage. Our results suggest that the GPS-CDF method performs well
when applied to large observational studies with multiple treatments that have large covariate
spaces.
Keywords: Causal Inference, Multinomial Treatments, Observational Study, Propensity
Score
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2.1 Introduction
Propensity scoring is utilized to overcome the covariate imbalance prevalent in
observational studies, enabling causal estimates of treatment outcome relationships, when
propensity scoring assumptions are met. Increasingly, large data sources including national
surveys, electronic health records (EHRs), and genome wide association studies (GWAS)
with phenotypic and covariate data are becoming publicly available. These observational data
sources are indexed by large covariate spaces for example, patient demographics, vital signs,
laboratory findings, medications/prescriptions, comorbidities, etc. (Patorno et al., 2014; Chen
and Moskowitz, 2016). It is of interest to use these potential pretreatment confounders in a
propensity model to ultimately assess the causal relationship between treatments and an
outcome. While these data types have gained rapid traction in the literature, propensity
scoring methods for assessing the effects of multiple (non-binary) treatments in the presence
of high-dimensional covariate spaces that result from these data sources are lacking
(Schneeweiss et al., 2009; Schuemie et al., 2012; Stuart et al., 2013; Low, Gallego and Shah,
2016; Ju et al., 2019).
Methods for utilizing propensity scoring in a binary treatment case are well studied
and established (e.g., Rosenbaum and Rubin 1983, 1984, 1985; Stuart, 2010; Gutman and
Rubin, 2015). However, generalizations to multiple unordered (multinomial) treatments are
more complicated. The generalized propensity score (GPS) is often used to extend the theory
of causal inference from a binary treatment setting to a multiple treatment setting (Joffe and
Rosenbaum, 1999; Imbens, 2000; Imai and Van Dyk, 2004). The GPS is defined as the
probability of receiving one of 𝐾𝐾 treatments conditional on a given set of observed covariates
(Imbens, 2000). Unlike the binary treatment case where the propensity score is a single value
representing the probability a subject was treated, the GPS is a vector, of length 𝐾𝐾,
27

representing the conditional probabilities of a subject being treated under each of the 𝐾𝐾
treatments.

An important distinction for causal inference using propensity scoring for
multinomial treatments are the two different summary measures of the treatment effect: the
average treatment effect (ATE) and the average treatment effect among the treated (ATT).
ATE is of interest for comparisons of the mean outcome when the entire population is
eligible for all treatments (McCaffrey et al., 2013). ATE is calculated by taking the
expectation across the entire population and is given by:

𝐴𝐴𝐴𝐴𝐸𝐸𝑘𝑘,𝑘𝑘′ = 𝐸𝐸 [𝑌𝑌(𝑘𝑘) − 𝑌𝑌 (𝑘𝑘 ′ )] = 𝐸𝐸 [𝑌𝑌(𝑘𝑘)] − 𝐸𝐸[𝑌𝑌(𝑘𝑘 ′ )]

(2.1)

where 𝑌𝑌 is the outcome for the comparison of treatment 𝑘𝑘 and treatment 𝑘𝑘′. ATT is of

interest when comparing the effectiveness of a particular treatment relative to the alternatives
available to the population of interest (McCaffrey et al., 2013). ATT finds the effect of the
treatment of interest among only those subjects who actually received the treatment. ATT is
formally defined as:

𝐴𝐴𝐴𝐴𝑇𝑇𝑘𝑘,𝑘𝑘′ = 𝐸𝐸 [𝑌𝑌(𝑘𝑘′) | 𝑍𝑍 = 𝑘𝑘] − 𝐸𝐸[𝑌𝑌(𝑘𝑘) | 𝑍𝑍 = 𝑘𝑘]

(2.2)

where 𝑌𝑌 is the outcome and 𝑍𝑍 is the treatment of interest.

Traditionally, methods for conducting propensity scoring in the presence of

multinomial treatments have relied on the GPS vector that is produced from some type of
multinomial regression model, e.g.,
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𝑃𝑃𝑃𝑃(𝑍𝑍𝑖𝑖 = 𝑘𝑘)
� = 𝜃𝜃𝑘𝑘 + 𝑥𝑥𝑖𝑖′ 𝛽𝛽𝑘𝑘
log �
𝑃𝑃𝑃𝑃(𝑍𝑍𝑖𝑖 = 𝐾𝐾 )

(2.3)

where 𝜃𝜃𝑘𝑘 is a constant, 𝛽𝛽𝑘𝑘 is a vector of regression coefficients, 𝑍𝑍 is the treatment received,

and 𝐾𝐾 is the total number of treatments, for 𝑘𝑘 = {1,2, … , 𝐾𝐾 − 1}. Commonly used methods of
conducting multinomial propensity scoring based on a parametrically derived GPS can be

classified into distance metrics (Seya and Yoshida, 2017; Rassen et al., 2013; Rubin, 1979;
Zhao, 2004), clustering techniques (Tu, Jiao and Koh, 2013; Lopez and Gutman, 2017), and
stratification, matching, and adjustment methods (Zanutto, Lu and Hornik, 2005; Huang et
al., 2005; Yang et al., 2016; Lechner, 2001; Feng et al., 2012).
Although many methods have been proposed to conduct multinomial propensity
scoring, there is no unified method, and current methods have drawbacks that diminish their
utility, especially in the context of big data. For example, as most of the aforementioned
methods exclusively estimate either ATE or ATT, their practical utility is limited.
Additionally, the distance based matching approach proposed by Rassen et. al cannot be
extended past three treatments (Rassen et al., 2013). Likewise, matching based on
Mahalanobi’s distance (Rubin, 1979; Zhao, 2004), does not perform well with more than 8
covariates or when covariates are not normally distributed (for example if they are noncontinuous (Gu and Rosenbaum, 1993; Stuart, 2010)). These are major limitations for big
data applications, which as previously stated, often have multiple treatment groups and a
large number of pretreatment confounders. Furthermore, although methods that produce
covariate balance using stratification, matching, and adjustment based on the GPS vector
have been studied in the multiple treatment setting (Zanutto, Lu and Hornik, 2005; Huang et
al., 2005; Yang et al., 2016; Lechner, 2001; Feng et al., 2012), a function that maps the GPS
vector to a scalar balancing score has not, to our knowledge, been proposed. A cornerstone
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of these current approaches is the estimation of treatment effects that are performed
separately for each treatment level. This simplifies the inherent problems that arise when
assessing balance among multiple treatment groups. However, since these approaches utilize
one element of the GPS vector instead of the full GPS vector (Greene, 2017), in some cases
they may suffer from a loss of information, resulting in suboptimal covariate balance.
To address the aforementioned issues without placing any parametric restrictions on
the relationship between treatment groups and pretreatment confounders, non-parametric
machine learning methods of estimating the GPS vector, such as generalized boosted models
(GBM), recursive partitioning, neural nets, and super learners have been proposed
(McCaffrey, Ridgeway and Morral, 2004; Setoguchi et al., 2008; McCaffrey et al., 2013;
Burgette, Griffin and McCaffrey, 2017; Ju et al., 2019). The most popular method, due to the
availability of a comprehensive R package, appears to be GBM (Burgette, Griffin and
McCaffrey, 2017) – this and other tree-based methods provide notable benefits over
parametric regression. For example, variable selection including the decision to
accommodate higher order or interaction terms in the model occurs automatically. This is of
particular importance when working with EHRs since there are a large number of potential
confounders available (McCaffrey et al., 2013). Further, the iterative estimation procedure
used by GBM, which fits regression trees that maximize the log likelihood in order to
produce a piecewise constant model, can easily be refined to provide the propensity score
model with the best balance between treatment groups (McCaffrey et al., 2013). After
estimating the GPS vector, inverse probability treatment weighting (IPTW), where the
weight is the inverse propensity of the treatment an individual actually received (Imbens,
2000; Feng et al., 2012; McCaffrey et al., 2013; Burgette, Griffin and McCaffrey, 2017), may
be either applied directly to the outcome (Feng et al., 2012) or utilized within weighted
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regression models (McCaffrey, 2013; Burgette, Griffin and McCaffrey, 2017) to estimate
ATEs. Additionally, weights derived from multiplying the inverse probability weight by the
probability of the target treatment may be used to estimate ATTs (McCaffrey et al., 2013;
Burgette, Griffin and McCaffrey, 2017).
One issue with utilizing machine learning methods to estimate the GPS vector is that
they are only compatible with IPTW. Matching and stratification cannot be utilized in the
outcome model since no obvious scalar balancing score is produced. Although this simplifies
many of the inherent issues that arise with multiple treatments, IPTW may produce unreliable
outcome estimates, with large sample variances, due to extreme weights (Busso, DiNardo,
McCrary, 2014; Lopez and Gutman, 2017; Li, Morgan, Zaslavsky, 2018). Alternative
weighting methods have been proposed that are less susceptible to these extremes (Hirano
and Imbens, 2001; Imai and Ratkovic, 2014; Li, Morgan, Zaslavsky, 2018). However, since
weighting directly uses the scalar estimated propensity score in determining the effect of
treatment (Austin, Grootendorst and Anderson, 2007; Rubin, 2004), as Rubin (Rubin, 2004)
suggests, this results in the greatest sensitivity to misspecification of the propensity score.
Furthermore, the utility of IPTW may diminish as the number of treatment groups increases
past 𝐾𝐾 = 3; Yang et al. (2016) showed that IPTW performs well in the presence of three

treatments but has inferior performance with six treatments. These limitations have precluded
the use of machine learning methods in propensity scoring over the last decade, despite their
promise.
In sum, while multinomial propensity score methods exist, they are somewhat ad hoc,
potentially difficult to implement, and do not have the flexibility of the scalar balancing score
obtained from binary propensity scoring. To address these limitations, this paper presents a
novel approach, the generalized propensity score cumulative distribution function (GPS-
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CDF), which maps a GPS vector to a single scalar value that can be used for propensity score
matching and stratification in order to produce causal inferences with multinomial
treatments. The methodology is a natural extension of the binary setting. It is tested via
simulation and applied to an EHR-derived study to evaluate the effect of vasopressor choice
on mortality in patients with non-traumatic aneurysmal subarachnoid hemorrhage. The
proposed GPS-CDF methodology is publicly available through the 𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺 R package
(Brown et al., 2019).

2.2 Methods
Since the GPS vector represents the probability a subject received each of the 𝐾𝐾

treatments conditional on a given set of observed covariates (Imbens, 2000), the GPS vector
can be thought of as a discrete probability distribution that can be used to create a probability
mass function (PMF) (Greene, 2017). In this way, subjects with similar shapes for their
PMFs will have similar values for their GPS vectors, which in turn means, on average, they
will have similar covariate distributions. A single scalar parameter function that can
accurately describe the shape of the PMF could be used as a balancing score to easily match
or stratify subjects.
The PMF is not a monotonically increasing or decreasing function. The shape of the
PMF will vary for each subject depending on their treatment probabilities; therefore,
estimating a one parameter function that describes the shape of the PMF is difficult. Instead,
a cumulative distribution function (CDF) can be created for each subject by summing across
values of the GPS vector. By definition, the CDF is a strictly increasing function bounded by
zero and one, so fitting a one parameter function to the shape of the CDF is possible. As the
CDF is a 1-to-1 function of the GPS vector, subjects with similar values for a one parameter
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function that maps the shape of the CDF will have similar GPS vectors. As such, a one
parameter power function can be used to model the CDF. The equation of this proposed
power function that maps the CDF of the GPS vector is given by:

exp(𝑎𝑎�)

𝑃𝑃(𝑍𝑍𝑖𝑖 ≤ 𝑑𝑑 ) = 𝐹𝐹𝑘𝑘 (𝑍𝑍) ≈ 𝑓𝑓(𝑎𝑎�) = 𝑑𝑑𝑘𝑘

for 𝑘𝑘 = 1, . . . , 𝐾𝐾 − 1

(2.4)

where the left side represents the CDF for the GPS vector, 𝑑𝑑𝑘𝑘 is a standardized treatment

dose which lies between 0 and 1, 𝑎𝑎� is the scalar that dictates the shape of the power function

fitting the CDF, and 𝑘𝑘 is the indicator of the treatment group. In a three treatment setting, for

example, the standardized dose 𝑑𝑑𝑘𝑘 is taken to be 0.33, 0.66 for the first two treatment groups

and equal to 1 for the final treatment group. The chosen power function in equation (2.4)

allows both convex and concave CDFs to be accurately modeled (Storer, 1989; O’Quigley,
Pepe and Fisher, 1990) as shown by Figure 2.1. Other one parameter functions (e.g.
exponential, logarithmic, sigmoid) might initially seem obvious to apply but do not have this
advantage (O’Quigley, Pepe and Fisher, 1990). Once the CDF has been calculated for each
subject, a non-linear least squares (NLS) algorithm (Marquardt, 1963) is used to fit the power
function. This NLS algorithm iteratively fits values for 𝑎𝑎�, the shape parameter, until the

residual distance between the CDF and fitted power function is minimized. Formally, NLS
estimation is given by:

exp(𝑎𝑎�)
min ∑𝐾𝐾−1
− 𝐹𝐹𝑘𝑘 (𝑍𝑍)�
𝑘𝑘=1 �𝑑𝑑𝑘𝑘
𝑎𝑎�

2

for 𝑘𝑘 = 1, . . . , 𝐾𝐾 − 1.

(2.5)

An important feature of the proposed method is its compatibility with any parametric or
machine learning model that produces a GPS vector. Currently, there are no methods for
multinomial treatment propensity scoring that are both “propensity model free” and produce
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a scalar balancing score that facilities matching and stratification. While it may initially
appear that other methods (e.g. multivariate distances, Kolmogorov-Smirnov test statistic,
isotonic regression, Kullback–Leibler divergence, etc.) could be used to differentiate CDFs
derived from the GPS vector, these methods do not result in a scalar balancing score.
Although these alternative options may be used to match subjects, they do not allow for
adjustment through stratification. The proposed approach in equation (2.4) will both
accurately describe the curvature of the CDF and also produce a single scalar balancing score
that can easily be used for both matching and stratification of subjects.
Unlike ordinal treatment settings where there is a natural ordering to the treatments,
multinomial treatments can be aligned in any order within the GPS vector. In a setting with
three multinomial treatments (A, B, and C), for example, the GPS vector can be ordered as
A-B-C, A-C-B, B-A-C, B-C-A, C-A-B, and C-B-A. Each ordering is intuitive and will
produce a different CDF, and subsequently a new shape parameter, 𝑎𝑎�, for each subject. Since
a balancing score is just a function of covariates such that the conditional distribution of the
covariates given the balancing score is the same for all treatment groups (Rosenbaum and
Rubin, 1983), for three multinomial treatments, there are 6 different balancing scores
produced by the proposed GPS-CDF method. By rearranging the GPS vector for all possible
orderings, 𝐾𝐾! balancing scores can be created in a 𝐾𝐾 treatment setting. As with standard

propensity score methods, covariate balance can be assessed after matching or stratification
based on each of the 𝐾𝐾! orderings of the GPS vector to choose the ordering and method that
creates the best covariate balance in the data. While this may at first appear ad hoc, it has

substantial precedent in the literature - several recently proposed propensity score methods
(e.g., Fong, Hazlett and Imai, 2018; Imai and Ratkovic, 2014; Papadogeorgou, Choirat and
Zigler, 2018) seek to optimize covariate balance before implementing propensity scoring in
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the outcome analysis. For example, the spatial propensity score method proposed by
Papadogeorgou et al. (2018) incorporates an automated data-driven process of selecting
matched pairs over a possible range of weights, and further selects the weight that achieves
the best covariate balance. In this way, the proposed iterative nature of finding the 𝑎𝑎� that

optimizes covariate balance is analgous to the aforementioned method. Covariate balance
should be assessed using each resultant 𝐾𝐾! balancing score produced by the GPS-CDF

method, and the ordering that achieves the best covariate balance, among all subjects, should
be retained for the outcome analysis.

2.2.1 GPS-CDF Matching
As the estimated power parameter, 𝑎𝑎�, is a scalar value, it can be used in either greedy

or optimal matching algorithms to pair subjects, with similar 𝑎𝑎� values, who received different
treatments. The proposed metric for matching is the absolute difference between the power
parameters for two subjects, 𝑎𝑎�𝑖𝑖 and 𝑎𝑎�𝑗𝑗 who received different treatments. Minimizing this
difference will jointly pair subjects with similar values of 𝑎𝑎� while ensuring the subjects

received different treatments. This metric for two subjects, 𝑖𝑖 and 𝑗𝑗, is given by equation (2.6).
∆𝑝𝑝 = ∆�𝒙𝒙𝑖𝑖 , 𝒙𝒙𝑗𝑗 � = |𝑎𝑎�𝑖𝑖 − 𝑎𝑎�𝑗𝑗 |

(2.6)

After the matching procedure is performed for each of the 𝐾𝐾! orderings of the GPS

vector, the order that creates matches with the best covariate balance should be retained for
the outcome analysis. As is standard with propensity score methods, we propose selecting the
ordering that minimizes the standardized mean difference (SMD) within matches (Austin,
2011; Burgette, Griffin and McCaffrey, 2017; Fong, Hazlett and Imai, 2018; Imai and
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Ratkovic, 2014; Lopez and Gutman, 2017; McCaffrey et al., 2013; Papadogeorgou, Choirat
and Zigler, 2018; Yang et al., 2016). Formally, this selection can be written as:

⎡
⎤
𝑀𝑀
⎛ 𝑥𝑥̅
⎞
⎢ 𝑃𝑃 𝑎𝑎�𝑘𝑘
⎥
𝑝𝑝,𝑚𝑚,𝑡𝑡𝑖𝑖 − 𝑥𝑥̅ 𝑝𝑝,𝑚𝑚,𝑡𝑡𝑗𝑗
⎟⎥
𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑛𝑛𝑎𝑎�𝑘𝑘 ⎢ � � � ⎜
⎟
⎢𝑝𝑝=1 𝑚𝑚=1 𝑡𝑡 ≠𝑡𝑡 ⎜ 𝑠𝑠 2
2
+ 𝑠𝑠𝑝𝑝,𝑚𝑚,𝑡𝑡𝑗𝑗 ⎥
𝑖𝑖 𝑗𝑗
� 𝑝𝑝,𝑚𝑚,𝑡𝑡𝑖𝑖
⎢
⎥
2
⎣
⎝
⎠⎦

(2.7)

where 𝑎𝑎�𝑘𝑘 is the 𝑎𝑎� derived from each 𝐾𝐾! ordering of the GPS vector, 𝑃𝑃 is the number of

covariates, 𝑀𝑀𝑎𝑎�𝑘𝑘 is the index for the number of matched pair treatment groups created from

each ordering of the GPS vector, and 𝑡𝑡𝑖𝑖 = 1, 2, . . . , 𝐾𝐾 represents the multinomial treatment

groups. The following steps detail the matching procedure:

1. Choose variables related to the treatments to include in the propensity model (see
Brookhart et al. (2006) for a detailed discussion of varaible selection for propensity models).
2. Estimate the GPS vector for each subject using any desired parametric or machine learning
model (i.e. multinomial logistic regression, GBM, etc.).
3. Choose an ordering of the 𝐾𝐾 treatments within the GPS vector.
4. Calculate the CDF of the ordered GPS vector for each subject.

5. Fit a one parameter power function to the CDF of each subject to obtain 𝑎𝑎�.
6. Calculate the ∆(𝑖𝑖,𝑗𝑗) matrix between all pairs of subjects.

7. Create matched pairs using a matching algorithm.

8. Repeat steps 3-7 for each additional (𝐾𝐾! − 1) ordering of the GPS vector.

9. Assess covariate balance after matching separately for each of the 𝐾𝐾! balancing scores via
SMD.

10. Retain the balancing score that creates matches with the best covariate balance.
11. Conduct a matched outcome analysis to estimate ATE or ATT (e.g. conditional logistic
regression).
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2.2.2 GPS-CDF Stratification
The method for stratification follows closely to the method proposed for matching.
Using the estimated power parameter, 𝑎𝑎�, strata can be created to group subjects with similar
values of 𝑎𝑎� who received different treatments. Thus within strata, subjects have similar

covariate distributions and received different treatments. Although any number of strata can
be created, it has been shown in previous studies that stratifying the data into quintiles
removes approximately 90% of the initial observed covariate imbalance (Cochran, 1968;
Rosenbaum and Rubin, 1984; Zanutto, Lu and Hornik, 2005; Austin, 2011).
As with the matching procedure, stratification can be performed for each of the 𝐾𝐾!

orderings of the GPS vector. Again, the ordering that creates the strata with the best covariate
balance should be retained for the outcome analysis. We propose selecting the ordering that
minimizes the SMD within strata (Austin, 2011; Burgette, Griffin and McCaffrey, 2017;
Fong, Hazlett and Imai, 2018; Imai and Ratkovic, 2014; Lopez and Gutman, 2017;
McCaffrey et al., 2013; Papadogeorgou, Choirat and Zigler, 2018; Yang et al., 2016).
Formally, this selection can be written as:

⎡
⎤
𝑆𝑆𝑎𝑎
� 𝑘𝑘
𝑃𝑃
⎛ 𝑥𝑥̅
⎞⎥
⎢
𝑝𝑝,𝑠𝑠,𝑡𝑡𝑖𝑖 − 𝑥𝑥̅ 𝑝𝑝,𝑠𝑠,𝑡𝑡𝑗𝑗
⎢
⎜
⎟⎥
𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑛𝑛𝑎𝑎�𝑘𝑘 � � �
⎢𝑝𝑝=1 𝑠𝑠=1 𝑡𝑡 ≠𝑡𝑡 ⎜ 𝑠𝑠 2 + 𝑠𝑠 2 ⎟⎥
𝑖𝑖 𝑗𝑗
𝑝𝑝,𝑠𝑠,𝑡𝑡𝑗𝑗 ⎥
� 𝑝𝑝,𝑠𝑠,𝑡𝑡𝑖𝑖
⎢
2
⎣
⎝
⎠⎦
where 𝑎𝑎�𝑘𝑘 is the 𝑎𝑎� derived from each 𝐾𝐾! ordering of the GPS vector, 𝑃𝑃 is the number of

(2.8)

covariates, 𝑆𝑆𝑎𝑎�𝑘𝑘 is the number of strata created for each ordering of the GPS vector, and 𝑡𝑡𝑖𝑖 =
1, 2, . . . , 𝐾𝐾 represents the multinomial treatment groups. The following steps detail the
stratification procedure:
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1. Repeat steps 1 and 2 from the CDF matching procedure.
2. Choose an ordering of the 𝐾𝐾 treatments within the GPS vector.
3. Calculate the CDF of the ordered GPS vector for each subject.

4. Fit a one parameter power function to the CDF of each subject to obtain 𝑎𝑎�.

5. Rank observations based on their value for the power parameter 𝑎𝑎� and separate the data
into quintiles.

6. Repeat steps 3-5 for each additional (𝐾𝐾! − 1) ordering of the GPS vector.

7. Assess covariate balance after stratification separately for each of the 𝐾𝐾! orderings via
SMD.

8. Retain the GPS vector ordering that creates strata with the best covariate balance.
9. Conduct a stratified outcome analysis to estimate ATE or ATT (e.g. conditional logistic
regression).

2.3 Simulation Study
A simulation study is conducted to determine how the GPS-CDF matching and
stratification methods perform under different data scenarios with varying degrees of model
misspecification. The design of the current simulation follows closely to several recently
published simulations that seek to be representative of real data (Austin, Grootendorst, and
Anderson, 2007; Fong, Hazlett and Imai, 2018; Greene, 2017). Four data scenarios are
considered with three treatment categories, one binary outcome, and nine baseline covariates.
Six covariates are associated with treatment assignment probability, and six covariates are
associated with outcome assignment probability, producing various levels of treatment and
outcome confounding. A table describing the associations of the baseline covariates with the
treatment and outcome variables is shown in Table 2.1. From the table, it can be observed
that 𝑥𝑥1 , 𝑥𝑥2 , 𝑥𝑥4 , and 𝑥𝑥5 are generated to be pretreatment confounders.

The four data scenarios considered within this simulation study are similar to those of

Fong et al. (Fong, Hazlett and Imai, 2018) and Greene (2017) and vary whether treatment
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and outcome assignment models are correctly specified. Incorrect specification is created
through inclusion of a non-linear term. The nine baseline covariates are multivariate
normally distributed with mean 0, variance 1, and covariances of 0.2.
Scenario 1 assumes both the treatment and outcome models are correct through
inclusion of only linear terms. The true treatment and outcome models are given by equations
(2.9) and (2.10), respectively.

log �

𝑃𝑃𝑃𝑃(𝑍𝑍𝑖𝑖 = 𝑘𝑘)
� = 𝜃𝜃𝑘𝑘 + 𝛽𝛽1,𝑘𝑘 𝑥𝑥𝑖𝑖,1 + 𝛽𝛽2,𝑘𝑘 𝑥𝑥𝑖𝑖,2 + 𝛽𝛽4,𝑘𝑘 𝑥𝑥𝑖𝑖,4 + 𝛽𝛽5,𝑘𝑘 𝑥𝑥𝑖𝑖,5 + 𝛽𝛽7 𝑥𝑥𝑖𝑖,7 + 𝛽𝛽8 𝑥𝑥𝑖𝑖,8
𝑃𝑃𝑃𝑃(𝑍𝑍𝑖𝑖 = 3)

(2.9)

for 𝑘𝑘 = 1,2, 𝜃𝜃 = (0.25, 0.3), 𝛽𝛽1 = 𝛽𝛽4 = (0.7, 0.4),
𝛽𝛽2 = 𝛽𝛽5 = (0.2, 0 .3), 𝛽𝛽7 = 0.6, and 𝛽𝛽8 = 0.2

𝑃𝑃𝑃𝑃(𝑌𝑌𝑖𝑖 = 1)
� = 𝛼𝛼 + 𝛽𝛽𝑍𝑍 𝑍𝑍𝑖𝑖 + 𝛽𝛽1 𝑥𝑥𝑖𝑖,1 + 𝛽𝛽2 𝑥𝑥𝑖𝑖,2 + 𝛽𝛽3 𝑥𝑥𝑖𝑖,3 + 𝛽𝛽4 𝑥𝑥𝑖𝑖,4 + 𝛽𝛽5 𝑥𝑥𝑖𝑖,5 + 𝛽𝛽6 𝑥𝑥𝑖𝑖,6
log �
1 − 𝑃𝑃𝑃𝑃(𝑌𝑌𝑖𝑖 = 1)

(2.10)

for 𝛼𝛼 = −0.2, 𝛽𝛽𝑍𝑍 = (−0.1, 0.6, 0.3), 𝛽𝛽1 = 𝛽𝛽2 = 𝛽𝛽3 = 0.6,
𝑎𝑎𝑎𝑎𝑎𝑎 𝛽𝛽4 = 𝛽𝛽5 = 𝛽𝛽6 = 0.4

The three level multinomial treatment and binary outcome variables are simulated by
sampling one value from a multinomial distribution and Bernoulli distribution using the
probabilities calculated from equation (2.9) and (2.10), respectively, as the probability
sampling weights. From the data generation procedure, the true treatment effects are 0.7, 0.4,
and -0.3 for treatment pairs (1, 2), (1, 3), and (2, 3), respectively.
Scenario 2 introduces a non-linear term based on a mis-measured variable,
(𝑥𝑥𝑖𝑖,1 + 0.5)2 , into the treatment assignment model, while the outcome model remains the

same as equation (2.10). The misspecified treatment model is given by:
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log �

𝑃𝑃𝑃𝑃(𝑍𝑍𝑖𝑖 = 𝑘𝑘)
� = 𝜃𝜃𝑘𝑘 + 𝛽𝛽1,𝑘𝑘 (𝑥𝑥𝑖𝑖,1 + 0.5)2 + 𝛽𝛽1,𝑘𝑘 𝑥𝑥𝑖𝑖,1 + 𝛽𝛽2,𝑘𝑘 𝑥𝑥𝑖𝑖,2 + 𝛽𝛽4,𝑘𝑘 𝑥𝑥𝑖𝑖,4 + 𝛽𝛽5,𝑘𝑘 𝑥𝑥𝑖𝑖,5 + 𝛽𝛽7 𝑥𝑥𝑖𝑖,7 + 𝛽𝛽8 𝑥𝑥𝑖𝑖,8
𝑃𝑃𝑃𝑃(𝑍𝑍𝑖𝑖 = 3)

(2.11)

for 𝑘𝑘 = 1,2, 𝜃𝜃 = (−0.5, 0), 𝛽𝛽1 = 𝛽𝛽4 = (0.7, 0.4),
𝛽𝛽2 = 𝛽𝛽5 = (0.2, 0 .3), 𝛽𝛽7 = 0.6, and 𝛽𝛽8 = 0.2.

Scenario 3 introduces a non-linear term based on a mis-measured variable,
(𝑥𝑥𝑖𝑖,1 + 0.5)2 , into the outcome assignment model, while the treatment model remains the

same as equation (2.9). The misspecified outcome model is given by:

log �

𝑃𝑃𝑃𝑃(𝑌𝑌𝑖𝑖 = 1)
� = 𝛼𝛼 + 𝛽𝛽𝑍𝑍 𝑍𝑍𝑖𝑖 + 0.5(𝑥𝑥𝑖𝑖,1 + 0.5)2 + 𝛽𝛽1 𝑥𝑥𝑖𝑖,1 + 𝛽𝛽2 𝑥𝑥𝑖𝑖,2 + 𝛽𝛽3 𝑥𝑥𝑖𝑖,3 + 𝛽𝛽4 𝑥𝑥𝑖𝑖,4 + 𝛽𝛽5 𝑥𝑥𝑖𝑖,5 + 𝛽𝛽6 𝑥𝑥𝑖𝑖,6
1 − 𝑃𝑃𝑃𝑃(𝑌𝑌𝑖𝑖 = 1)

(2.12)

for 𝛼𝛼 = −0.8, 𝛽𝛽𝑍𝑍 = (−0.1, 0.6, 0.3), 𝛽𝛽1 = 𝛽𝛽2 = 𝛽𝛽3 = 0.6,
𝑎𝑎𝑎𝑎𝑎𝑎 𝛽𝛽4 = 𝛽𝛽5 = 𝛽𝛽6 = 0.4.

Finally in Scenario 4, both the treatment and outcome models are misspecified using
the treatment and outcome assignment models detailed in equations (2.11) and (2.12).

2.4 Results
For each data scenario considered, 1000 datasets each containing 1000 observations
are generated. Five analytic tools are used to estimate and compare ATEs: unadjusted (crude
odds ratio) model, adjusted (adjusted odds ratio) model, GBM with IPTW, GPS-CDF greedy
matching, and GPS-CDF stratification. The GBM propensity model adjusts for all nine
baseline covariates. Additionally, the GPS vector generated through GBM is used for GPSCDF matching and stratification, and a caliper of 0.25 standard deviations of 𝑎𝑎� is used for
GPS-CDF greedy matching (Cochran and Rubin, 1973; Lunt, 2014). Outcome models to
obtain ATE estimates utilize logistic regression for the unadjusted and adjusted models,
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survey-weighted generalized linear models for GBM weighting, and conditional logistic
regression for GPS-CDF matching and stratification. Furthermore, outcome models (with the
exception of the unadjusted model) adjusted for all first order covariates associated with
outcome assignment (Rosenbaum and Rubin, 1984; Hirano and Imbens, 2001; Imai and Van
Dyk, 2004).
Figure 2.2 is a graphical depiction of the amount of covariate balance achieved by
each analytical tool under both the correctly and incorrectly specified treatment model. The
adjusted model was not included in this balance assessment plot as it has the same covariate
balance as the unadjusted model. The plot depicts the maximum pairwise SMD for each of
the nine baseline covariates within each of the simulated datasets (Lopez and Gutman, 2017).
For each treatment pair, the SMD is calculated and the maximum value across treatment
pairs is retained. Methods that achieve covariate balance have smaller maximum SMD
values.
The three propensity based methods achieve better covariate balance, on average,
compared to the original unweighted data. Within the correctly specified treatment model
(left plot), GBM weighting produces better balance than both GPS-CDF matching and
stratification. GPS-CDF matching and stratification produce similar balance in the correctly
specified treatment model, but it appears that GPS-CDF stratification is less prone to outliers.
Within the incorrectly specified treatment model (right plot), GBM weighting and GPS-CDF
matching produce similar balance results. GPS-CDF stratification produces slightly worse
balance than GBM weighting and GPS-CDF matching, but still produces better balance than
the original data.
For each of the data scenarios considered, the five analysis methods are compared
using average bias, mean squared error (MSE), and coverage probability of the estimated
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ATEs. As there are three treatment groups, the performance of each method is assed for each
of the three treatment group comparisons. Figure 2.3 shows the distribution of the ATE
estimates from each analytical method under each data scenario between treatment 1 and
treatment 3. The true pairwise treatment effect of 0.4 is included as the dotted horizontal line.
Within Scenario 1, all methods produce estimates with minimal bias and high
coverage probabilities, with the exception of the unadjusted model. The adjusted model,
which does not include any propensity scoring, actually has the smallest MSE compared to
the methods that include propensity models. This result was anticipated as there is no
misspecification in either the treatment or outcome model under this data scenario.
Additionally, GBM weighting performs better in terms of bias and MSE compared to GPSCDF matching. However, even though GBM weighting produces better balance than GPSCDF stratification, as indicated in Figure 2.2, GPS-CDF stratification has lower bias and
higher coverage probability compared to GBM weighting. In Scenario 2, where the treatment
model is misspecified but the outcome model is correct (Figure 2.3, Scenario 2), results are
consistent with Scenario 1. The adjusted model performs better than GBM in terms of bias,
MSE, and coverage probability. Again, GPS-CDF stratification produces lower bias than all
other methods and obtained the highest coverage probability.
For Scenario 3, which includes a correctly specified treatment model but misspecified
outcome model (Figure 2.3, Scenario 3), GBM weighting has lower bias but higher MSE
compared to the adjusted model. GPS-CDF matching and stratification have lower bias
compared to all other methods, with both GPS-CDF methods outperforming GBM weighting
in terms of coverage probability. Finally in Scenario 4 (Figure 2.3 Scenario 4), the adjusted
model, GBM weighting, and GPS-CDF matching all fail to obtain accurate ATE estimates.
GPS-CDF stratification is still able to produce minimally biased ATE estimates while
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maintaining low MSE and coverage probability close to 0.9 when both the treatment and
outcome models are misspecified.
The ATE estimate results from the comparisons between treatments 1 and 2
(Appendix A: Supplemental Figure 1) and between treatments 2 and 3 (Appendix A:
Supplemental Figure 2) are consistent with those detailed above. GPS-CDF stratification
produces ATE estimates with minimal bias and MSE, while maintaining high coverage
probability across all data scenarios.
Finally, Supplemental Figure 3 (Appendix A) is a graphical representation of the
CDF mapping produced by the GPS-CDF method under 4 different multinomial treatment
group scenarios: 3, 4, 6, and 10 treatments. For each multinomial treatment group, 1000
subjects are simulated in a manner similar to the above simulation study, and GBM is used to
estimate the GPS vector for each simulated subject. The subsequent CDF vector for each
subject is found by summing across the subject specific GPS vectors. The GPS-CDF method
is then applied to derive subject specific 𝑎𝑎� values. Each panel of Supplemental Figure 3

(Appendix A) shows the resultant CDF vector and estimated power function for 5 simulated
subjects across each treatment group scenario. Supplemental Figure 3 (Appendix A) indicates
that as the number of treatment groups increase, the power function, based on 𝑎𝑎�, still

accurately maps the CDF of the GPS vector. The average of the absolute difference between
the CDF of the GPS vector and the produced power function is 0.034, 0.047, 0.049, and
0.055 for 3, 4, 6, and 10 treatments, respectively, for all simulated subjects.

2.5 Data Applications
To illustrate the utility of the above proposed methods, two data applications are
conducted. First, electronic health records (EHR) data from the Cerner Health Facts database
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are used to analyze the relationship between vasopressors and mortality in patients with nontraumatic aneurysmal subarachnoid hemorrhage (SAH). Additionally, the GPS-CDF methods
are further applied to the Emergency Truncal Hemorrhage Control Study (ETHCS), a
prospective observational study, to determine whether emerging hemorrhage control
interventions influence patient mortality.

2.5.1 Cerner Health Facts database
The utility of the novel approach is demonstrated on EHR data from the Cerner
Health Facts database. The database was used to analyze the relationship between
vasopressor choice and mortality in patients with non-traumatic aneurysmal subarachnoid
hemorrhage (SAH). SAH is defined as a blood vessel that bursts in the brain, and is a
devastating cerebrovascular condition not only due to the effect of the hemorrhage but also
the complicated treatment regimens required to manage such patients. A major complication
resulting from SAH includes delayed cerebral ischemia (DCI), which is a main source of
morbidity following SAH (Roy et al., 2017). Although current guidelines suggest
maintaining an elevated blood pressure after management of an aneurysm may reduce the
incidence of DCI, there is little data to suggest which vasopressor is the most efficacious to
achieving this end with regards to mortality. The effectiveness of the three most commonly
accepted drugs used to achieve an increase in blood pressure (dopamine, phenylephrine, and
norepinephrine) are studied in relation to mortality in patients with non-traumatic SAH.
The study population included in the current analysis has been previously described
(Williams et al., submitted). Briefly, the Cerner Health Facts EHR database was queried from
years 2000 to 2015 to select adult patients (over age 17) with a new diagnosis of aneurysmal
SAH based on ICD-9 code 430. Only patients who received infusions of dopamine,
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phenylephrine, or norepinephrine were included in the study population (Williams et al.,
submitted). Among the 4,850 patients that met the above study inclusion criteria, 40 patients
presented with multiple first vasopressor treatments; these patients were excluded from the
cohort. Furthermore, patients whose diagnosis included a traumatic cause of SAH (based on
ICD 9 codes: 800.2x, 800.7x, 801.2x, 801.7x, 803.2x, 803.7x, 804.2x, 804.7x, 852.x) or with
unknown mortality status were excluded from the study population leaving 2,634 patients in
the final cohort.
The propensity score analysis presented here includes 2,417 patients with complete
data for demographic variables (age, gender, race, and marital status) as well as pretreatment
medication variables. Of the patients included in the analysis, 492, 1,253, and 672 were
administered dopamine, phenylephrine, and norepinephrine, respectively. In total, 170
pretreatment variables are entered into GBM in order to produce patient specific GPS
vectors. More details on variable selection as well as variables included in the propensity
model can be found in previous work (Williams et al., submitted).
The five analytical methods investigated within the simulation study are applied to
this EHR dataset to determine the causal relationship between vasopressor choice and
mortality. A visual representation of the covariate balance achieved by each method is
depicted in Figure 2.4. The left plot shows maximum pairwise SMD for each potential
pretreatment confounder. Similarly, the right plot shows the average pairwise SMD, which is
calculated by averaging the SMD for each potential pretreatment confounder across
treatment pairs. It has been suggested that values of SMD less than 0.2 indicate small levels
of covariate imbalance (Cohen, 1988; McCaffrey et al., 2013). Based on this cutoff, both
GBM weighting and GPS-CDF matching produce better covariate balance compared to the
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original data, while GPS-CDF stratification produces less satisfactory levels of covariate
balance.
As all subjects within this EHR dataset were eligible for all three treatments, ATE is
the estimand of interest. Results from applying each of the five analytical methods, assessed
within the simulation study, are shown in Table 2.2. GPS-CDF matching and stratification
show that the odds of mortality are significantly higher in patients who received dopamine
versus patients who received phenylephrine (ORGPS-CDF Matching = 1.53, 95% CI [1.11, 2.10], p
= 0.008; ORGPS-CDF Stratification = 2.59, 95% CI [2.03, 3.31], p = <0.001). Patients receiving
norepinephrine are found to have a higher odds of mortality versus patients receiving
phenylephrine when analyses are conducted using the GPS-CDF stratification method
(ORGPS-CDF Stratification = 3.21, 95% CI [2.55, 3.31], p = <0.001), but this association is not
significant with GPS-CDF matching (ORGPS-CDF Matching = 1.41, 95% CI [1.00, 1.99], p =
0.051). Furthermore, GPS-CDF matching and stratification do not show any significant
differences in the odds of mortality between patients who received dopamine and patients
who received norepinephrine.
Importantly, all three propensity scoring approaches applied attenuate the unadjusted
and covariate adjusted association between vasopressor choice and mortality. Overall, it does
appear that phenylephrine is superior to dopamine in relation to mortality in patients with
non-traumatic SAH, but the comparison between phenylephrine and norepinephrine remains
unclear. Although results from GBM weighting indicate nearly a 50% reduction in mortality
in patients given phenylephrine, the effects of vasopressor choice on patient mortality are not
as strong when the analyses are conducted using GPS-CDF matching. GPS-CDF matching
creates satisfactory levels of covariate balance within the data and further attenuates the
association between vasopressor choice and mortality. Again, outcome models to obtain
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ATEs utilize logistic regression, survey-weighted generalized linear models, and conditional
logistic regression for the unadjusted and adjusted model, GBM weighting, and GPS-CDF
matching and stratification, respectively. Additionally, the GPS-CDF approach is
computationally quick; results were available in 8 minutes using a dual-core Intel Core i33110M with 4 GB RAM.

2.5.2 Emergency Truncal Hemorrhage Control Study
Severe hemorrhage of the non-compressible torso is the leading cause of potentially
survivable deaths in trauma cases. Non-compressible torso hemorrhage (NCTH) is defined as
blood loss due to trauma of the torso (chest, abdomen, and pelvis), pulmonary parenchyma,
solid abdominal organs, and disruption of the bony pelvis causing hypotension or shock
(Stannard, Eliason and Rasmussen, 2011; Eastridge et al., 2012; Kisat et al., 2013). A new
treatment, namely, resuscitative endovascular balloon occlusion of the aorta (REBOA), is a
technique that could temporarily mitigate hemorrhage from the abdomen and pelvis. ETHCS
aims to compare various hemorrhage control techniques (laparotomy, thoracotomy, and
REBOA) in relation to patient mortality.
As ETHCS is an observational study, and patients undergoing REBOA or other
procedures (laparotomy or thoracotomy) have different covariate distributions, it is an
excellent example for the utility of the GPS-CDF multinomial propensity score method. The
current analysis contains 409 subjects, of which 264 (64.5%), 67 (16.4%), and 78 (19.1%)
were treated with laparotomy, thoracotomy, and REBOA, respectively. Again, the five
analytical methods investigated within the simulation study are applied to this ETHCS
dataset to determine the causal relationship between hemorrhage control techniques and
mortality. A visual representation of the covariate balance achieved by each method is
depicted in Figure 2.5. The plot shows the average pairwise SMD for all pre-treatment
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confounders: age, race, gender, injury mechanism, and study site. Based on Figure 2.5, GPSCDF matching produces better covariate balance compared to all other methods investigated.
Again as all subjects were eligible for all three hemorrhage control techniques, ATE
is the estimand of interest. Mortality results were not computed for comparisons with the
thoracotomy group, as 94% of subjects within this group died. GPS-CDF matching shows
that the odds of mortality are not significantly different for patients treated with REBOA
compared to patients treated with laparotomy (ORGPS-CDF Matching = 5.75, 95% CI [0.98,
33.83], p = 0.053). Conversely, results within the unadjusted and GBM weighted models do
indicate a significant difference in mortality between these two techniques (ORUnadjusted=
6.54, 95% CI [3.70, 11.56], p <0.001; ORGBM Weighted = 8.31, 95% CI [3.46, 19.94], p <0.001).
As the balance achieved via GPS-CDF matching is by far superior to any other method
investigated (Figure 2.5), the results suggest that there is no difference in mortality between
hemorrhage control techniques (REBOA and laparotomy) within the study population.

2.6 Discussion
Although methods exist to conduct propensity scoring in the presence of multinomial
treatments (e.g. Seya and Yoshida, 2017; Rassen et al., 2013; Rubin, 1979; Zhao, 2004; Tu,
Jiao and Koh, 2013; Lopez and Gutman, 2017; Zanutto, Lu and Hornik, 2005; Huang et al.,
2005; Yang et al., 2016; Lechner, 2001; Feng et al., 2012), few methods have the capability
and flexibility to estimate both ATE and ATT and correctly model data sources that present
with large covariate spaces. Recently, researchers have advocated for the use of machine
learning propensity models to produce more accurate GPS vectors especially in the presence
of a large covariate space (Setoguchi et al., 2008; Guertin et al., 2016; Chen and Moskowitz,
2016). Although the benefits of using GBM and other machine learning methods as detailed
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above, are apparent, there are still drawbacks to these methods that need to be addressed.
Currently, the GPS vector produced by machine learning methods is adjusted in outcome
analysis via IPTW. Although IPTW is an easily adaptable method in order to produce causal
treatment effect estimates, Rubin (Rubin, 2004) suggests that weighting directly on the
propensity score leads to a higher degree of sensitivity to model misspecification.
Furthermore, via simulation, Yang et al. (2016) show that when presented with six treatment
groups (not an impossibly large number when considering EHR-derived studies),
implementation of the GPS via IPTW leads to extreme weights. For example, the maximum
weights reported by Yang et al. (2016) are 95.8 within in a three treatment scenario and
185.1 within a six treatment scenario. Although these extreme weights may not adversely
impact covariate balance, they will lead to inaccurate ATEs/ATTs. Given the published
limitations for IPTW for multiple treatments propensity scoring, this paper derived and tested
via simulation and practice, a novel multinomial propensity scoring technique that utilizes
the entire GPS vector. The GPS-CDF method directly maps the GPS vector resulting from
any propensity model to a scalar value that is easily used for matching and stratification to
produce either ATEs or ATTs. As this method generates 𝐾𝐾! balancing scores, it follows

closely to the current opinion in the literature of the ‘covariate balancing propensity score’
(Fong, Hazlett and Imai, 2018; Imai and Ratkovic, 2014) and the ‘distance adjusted

propensity score’ (Papadogeorgou, Choirat and Zigler, 2018).
The proposed method of mapping the CDF of the GPS vector is given by equation
(2.4). While other methods may be used to map CDFs (e.g. Kolmogorov-Smirnov test
statistic, isotonic regression, Kullback–Leibler divergence, etc.), they do not result in a scalar
balancing score, analogous to the scalar value derived within binary treatment propensity
scoring. For example, the Kolmogorov-Smirnov test statistic tests the equality of CDFs
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through a distance based metric (Massey, 1951). Although this approach may be used to
match subjects with similar CDFs, the resultant pairwise distances cannot be easily adapted
to stratify subjects. Furthermore, other common one parameter functions (e.g. exponential,
logarithmic, sigmoid) do not have the same flexibility as the power function for mapping
CDFs that present with both concave and convex shapes. Thus the proposed GPS-CDF
method utilizes a one parameter power function in order to accurately map CDFs via a scalar
value, which may be used to match and stratify subjects.
The current simulation study closely followed several recently published simulations
(Austin, Grootendorst and Anderson, 2007; Fong, Hazlett and Imai, 2018; Greene, 2017);
matching and stratification via the GPS-CDF method produced better covariate balance than
the original data in both the correctly and incorrectly specified treatment model. Although
GBM weighting produced better covariate balance compared to GPS-CDF matching and
stratification within the correctly specified treatment model, similar to results presented by
Fong et al. (2018), this increased balance did not translate to more accurate ATE estimates.
GBM weighting produced highly biased estimates compared to GPS-CDF stratification for
each treatment comparison when both the treatment and outcome models were misspecificed.
Unlike IPTW which has been shown to produce unreliable estimates in the presence
of multiple treatment groups (Yang et al., 2016), the GPS-CDF method is still valid. Using
data simulated under different multinomial treatment group scenarios, the GPS-CDF method
was able to accurately map CDFs of the GPS even in the presence of numerous treatment
groups. When presented with 10 treatments, the average difference between the true CDF of
the GPS vector and the estimated power function was minimal. Since the mapping
capabilities of the method was shown to still be valid even in the presence of numerous
treatment groups, the GPS-CDF method may produce more accurate causal inference
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estimates compared to those derived by IPTW, especially in the presence of multiple
treatment groups.
Finally, the performance and utility of the GPS-CDF method was further
demonstrated using two data applications. First, data from the Cerner Health Facts database
were queried in order to assess the association between vasopressor choice and mortality in
patients with non-traumatic SAH. Overall, the novel multinomial propensity analysis
approach, GPS-CDF, had low computational burden and produced better covariate balance
compared to the original (unadjusted) data when applied via matching. Additionally, this
EHR data example demonstrates the easy applicability of the GPS-CDF approach. These
results further indicate that prospective studies should be conducted in order to determine
which vasopressor is the most efficacious for patients with non-traumatic SAH. Additionally,
the GPS-CDF methods were applied to the ETHCS to determine whether emerging
hemorrhage control interventions influence patient mortality. These results demonstrate that
REBOA has a similar effect on patient mortality compared to laparotomy.

2.7 Conclusion
This paper details the derivation and application of the GPS-CDF method that
removes covariate imbalance in observational studies with multinomial treatments.
Currently, no methods exist that transform the GPS vector into a single number, analogous to
the single scalar balancing score found in binary treatment propensity scoring. Using a NLS
algorithm, the GPS-CDF method directly maps any GPS vector to a scalar value which easily
facilitates either matching or stratification in order to produce causal treatment effect
estimates. Importantly, the scalar value derived from the GPS-CDF method can be adapted to
produce either ATE or ATT estimates. Our detailed simulation study found that
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implementation of the GPS-CDF method via stratification may lead to less biased causal
inference estimates compared to methods based on IPTW. Furthermore, when applied to an
EHR data set, the GPS-CDF method indicates that phenylephrine may be the superior
vasopressor choice for patients that present with non-traumatic SAH.
There are limitations of this study. First, the EHR data application was derived from
the Cerner Health Facts database, which contained a large number of patients with complete
covariate data. Patients were included in the analysis based on a new diagnoses of SAH, but
their diagnosis could not be confirmed via imaging. Additionally, due to the absence of
baseline diagnostic variables, there is of course the possibility of unmeasured confounding
within the analysis, as with any propensity score analysis, especially one derived from EHR.
Furthermore, within the ETHCS data application, 94% of patients who received thoracotomy
died. Thus meaningful analyses were not able to be conducted using this treatment group.
The GPS-CDF method presented here gives researchers more options when
conducting multinomial treatment propensity scoring. This novel method can be used in
conjunction with current machine learning methods in order to better facilitate propensity
score adjustment in the presence of big data. Future studies should further evaluate the use of
the GPS-CDF method when conducting propensity scoring with multinomial treatments in
the context of relevant research questions. Open-source software is available to help facilitate
the use of the proposed method in practice (Brown et al., 2019).
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Strongly Associated
with Outcome
Moderately Associated
with Outcome
Independent of
Outcome

Strongly Associated
with Treatment

Moderately Associated
with Treatment

Independent of
Treatment

𝑥𝑥1

𝑥𝑥2

𝑥𝑥3

𝑥𝑥7

𝑥𝑥8

𝑥𝑥9

𝑥𝑥4

𝑥𝑥5

𝑥𝑥6

Table 2.1. True association between baseline covariates with treatment and outcome. Note,
𝑥𝑥1 , 𝑥𝑥2 , 𝑥𝑥4 , and 𝑥𝑥5 are simulated to be pretreatment confounders.
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Norepinephrine vs Phenylephrine
OR [95% CI]
p-value
2.53 [2.08-3.09]
<0.001
2.63 [2.15-3.22]
<0.001
2.24 [1.80-2.80]
<0.001
1.41 [1.00-1.99]
0.051
3.21 [2.55-3.31]
<0.001

Dopamine vs Norepinephrine
OR [95% CI]
p-value
1.21 [0.96-1.53]
0.110
1.15 [0.91-1.45]
0.253
0.97 [0.75-1.27]
0.852
1.09 [0.79-1.49]
0.610
0.81 [0.61-1.07]
0.138

age at baseline, gender, race, and marital status.

vasopressor and mortality within the EHR dataset. Outcome models (with the exception of the unadjusted model) adjusted for

Table 2.2. Model estimates after applying each analytical method to SAH patients to determine the association between

Analytical Method
Unadjusted
Adjusted
GBM Weighted
GPS-CDF Greedy Matched
GPS-CDF Stratification

Dopamine vs Phenylephrine
OR [95% CI]
p-value
3.06 [2.46-3.81]
<0.001
3.02 [2.42-3.76]
<0.001
2.19 [1.70-2.81]
<0.001
1.53 [1.11-2.10]
0.008
2.59 [2.03-3.31]
<0.001

Figure 2.1. Graphical representation of the convex and concave modeling produced by the
power function.
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Figure 2.2. Graphical representation of the covariate balance achieved by each method under
the correctly specified and incorrectly specified treatment assignment models. SMD was
calculated for all baseline covariates within each treatment pair, and the maximum SMD
across treatment pairs was retained.
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Figure 2.3. Distribution of the ATE for each method under each scenario between treatment 1
and treatment 3. The true ATE value of 0.4 is included as the dotted horizontal line.
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Figure 2.4. Graphical representation of the covariate balance achieved by each method for
SAH patients within the Cerner Health Facts EHR database. The left plot presents the
maximum pairwise SMD across treatment groups for each potential confounder. The right
plot presents the average pairwise SMD across treatment groups for each potential
confounder.
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Figure 2.5. Graphical representation of the covariate balance achieved by each method for
hemorrhage patients within the Emergency Truncal Hemorrhage Control Study. The plot
presents the average pairwise SMD across treatment groups for each potential confounder.
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Abstract
Continuous treatments propensity scoring remains understudied, as the majority of
methods are focused on the binary treatment setting. Current propensity score methods for
continuous treatments typically rely on weighting in order to produce causal estimates. It has
been shown that in some cases, weighting methods can result in worse covariate balance than
had no adjustments been made to the data. Furthermore, weighting is not always stable, and
resultant estimates may be unreliable due to extreme weights. These issues motivate the
current development of novel propensity score stratification techniques to be used with
continuous treatments. Specifically, the generalized propensity score cumulative distribution
function (GPS-CDF) and the nonparametric GPS-CDF (npGPS-CDF) approaches are
introduced. Empirical CDFs are used to stratify subjects based on pretreatment confounders,
in order to produce causal estimates. A detailed simulation study shows superiority of these
new stratification methods based on the empirical CDF, when compared to standard
weighting techniques. The proposed methods are applied to the “Mexican American Tobacco
use in Children” (MATCh) study to determine the causal relationship between continuous
exposure to smoking imagery in movies, and smoking behavior among Mexican-American
adolescents. These promising results provide investigators with new options for
implementing continuous treatment propensity scoring.

Keywords: Causal Inference, Continuous Treatment, Observational Study, Propensity Score
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3.1 Introduction
Propensity scoring is often used to make causal inference about a treatment/exposureoutcome relationship in non-randomized observational studies. Although methods for binary
and more recently, multiple treatments have been well-studied (e.g., Rosenbaum and Rubin,
1983, 1984, 1985; Joffe and Rosenbaum, 1999; Imbens, 2000; Imai and Van Dyk, 2004),
there has been less research devoted to propensity score methods for continuous treatments.
In this paper, continuous treatments refer to treatment assignment (e.g. dosing trials) or
continuous exposures (e.g. environmental exposures). In the presence of continuous
treatments, investigators may instead dichotomize or categorize the treatment in order to
utilize more well-established propensity score techniques (e.g. Chertow, Normand, and
McNeil, 2004; Davidson et al., 2006; Donohue and Ho, 2007; Flores-Lagunes, Gonzalez, and
Neumann, 2007; Harder, Stuart, and Anthony, 2008; Boyd, Epstein, and Martin, 2010;
Nielsen et al., 2011; Greene, 2017). However, it has been shown that categorization of a
continuous treatment may lead to loss of information and subsequent decrease in power when
conducting outcome analyses (Royston, Altman, and Sauerbrei, 2006; Zhu, Coffman, and
Ghosh, 2015; Fong, Hazlett, and Imai, 2018). Also, not analyzing exposures on their original
scale can produce clinical interpretations that are awkward to domain-area researchers.
Propensity scoring methods directly applicable to continuous exposures have been
proposed. For example, maximum likelihood estimates (MLEs) derived from linear models
have been used to estimate the generalized propensity score (GPS) (Robins, Hernan, and
Brumback, 2000; Imai and Van Dyk, 2004; Hirano and Imbens, 2004). In practice, the GPS
can be obtained by fitting a linear regression model of the form
𝑇𝑇 = 𝜷𝜷𝜷𝜷 + 𝜀𝜀
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(3.1)

where 𝑇𝑇 is a continuous treatment, 𝑿𝑿 is a vector of potential confounders, and
𝜀𝜀 ~ 𝑁𝑁(0, 𝜎𝜎 2 ). The GPS for individual 𝑖𝑖, is estimated as,
𝑅𝑅�𝑖𝑖 =

1

√2𝜋𝜋𝜎𝜎� 2

exp �−

1
2
�𝑇𝑇𝑖𝑖 − 𝑇𝑇�𝑖𝑖 � �
2
2𝜎𝜎�

(3.2)

(Hirano and Imbens, 2004). The GPS is then used to remove covariate bias by first
estimating the conditional expectation of the outcome as a function of the treatment level (𝑇𝑇)
and the GPS (𝑅𝑅),
𝛽𝛽 (𝑡𝑡, 𝑟𝑟) = 𝐸𝐸[𝑌𝑌|𝑇𝑇 = 𝑡𝑡, 𝑅𝑅 = 𝑟𝑟]

(3.3)

(Hirano and Imbens, 2004). The dose-response function, i.e. the average response in the
sample, is then estimated at a particular treatment level by averaging equation (3.3) over the
GPS at that level of treatment,
𝜇𝜇(𝑡𝑡) = 𝐸𝐸�𝛽𝛽�𝑡𝑡, 𝑟𝑟(𝑡𝑡, 𝑋𝑋)��

(3.4)

(Hirano and Imbens, 2004). By calculating the dose response function at two treatment
levels, i.e. 𝜇𝜇 (𝑡𝑡1 ) and 𝜇𝜇 (𝑡𝑡2 ), the mean change in the outcome can be estimated (Austin

2018b). In practice, although the estimated GPS, 𝑅𝑅�𝑖𝑖 , can be applied directly in regression

� 𝑿𝑿𝒊𝒊 , can be utilized for matching
adjustment (Hirano and Imbens, 2004), or the scalar value, 𝜷𝜷
or stratification (Imai and Van Dyk, 2004), to produce causal estimates; using the GPS in a

weighted outcome analyses has been prioritized recently (e.g., Robins et al., 2000; Zhu et al.,
2015; Schuler, Chu, and Coffman, 2016; Fong et al., 2018; Austin, 2018a; Austin, 2018b).
Specifically, Robins et al. (2000) propose using the GPS to produce causal estimates
using inverse probability weighting (IPW) (Robins et al., 2000). Briefly, IPW weights each
individual with the inverse of the probability of receiving the treatment they actually
received, given the covariates. By up-weighting those individuals less likely to receive the
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treatment, IPW has the advantage of giving more weight in the analysis to subjects with
dissimilar covariate distributions than subjects with similar covariate profiles (i.e. subject
specific covariate values) within the same treatment level. In the calculation of 𝑅𝑅�𝑖𝑖 , subjects

with unexpected covariate distributions will have large estimates for 𝑇𝑇𝑖𝑖 − 𝑇𝑇�𝑖𝑖 , and conversely
will have small values for 𝑅𝑅�𝑖𝑖 . Thus, the IPW, given by
𝑤𝑤𝑖𝑖 =

1
𝑅𝑅�𝑖𝑖

(3.5)

will be higher, effectively giving more weight to subjects that have unexpected covariate
distributions based on their continuous treatment level. Weights of the above form have
infinite variance, so a stabilizing factor is applied to 𝑤𝑤𝑖𝑖 in practice, called, 𝑊𝑊 (𝑇𝑇𝑖𝑖 ), (Robins et

al., 2000), given by the marginal density of 𝑇𝑇, which may be estimated by first fitting an
intercept only model of the form

𝑇𝑇 = 𝛽𝛽0 + 𝜀𝜀

(3.6)

2
�. The stabilizing factor is estimated as
where 𝜀𝜀 ~ 𝑁𝑁�0, 𝜎𝜎𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠

� (𝑇𝑇𝑖𝑖 ) =
𝑊𝑊

1

2
�2𝜋𝜋𝜎𝜎�𝑠𝑠𝑠𝑠𝑚𝑚𝑝𝑝𝑝𝑝𝑝𝑝

exp �−

1

2
2𝜎𝜎�𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠

(𝑇𝑇𝑖𝑖 − 𝜇𝜇̂ )2 �

(3.7)

where 𝜇𝜇̂ is the mean treatment value of the sample (Austin, 2018b). The final estimated
stabilized IPW is given by

𝑠𝑠𝑠𝑠𝑖𝑖 =

� (𝑇𝑇𝑖𝑖 )
𝑊𝑊
,
𝑅𝑅�𝑖𝑖

(3.8)

which is utilized in a weighted outcome regression of the form
𝐸𝐸 (𝑌𝑌|𝑇𝑇) = 𝛼𝛼 + 𝛽𝛽𝑇𝑇 𝑇𝑇

in order to estimate the average treatment effect (ATE) (Schuler et al., 2016).
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(3.9)

Although the calculation of these weights is straightforward, the MLE method
detailed above relies heavily on correctly specifying the linear treatment model. If the model
is not correctly specified or the model assumptions are not met (e.g., deviations from
normality of errors), it has been shown that the MLE method can produce extreme weights
that can lead to severely biased causal inference estimates (Fong et al., 2018). Therefore,
methods that operate outside of the MLE framework may produce better weights, resulting in
more covariate balance, and less biased estimates of the outcome.
Nonparametric methods of estimating the GPS vector have been shown to provide
more accurate estimates of the GPS compared to parametric regression (Bia et al., 2014; Zhu
et al., 2015). One such method that has gathered traction is the generalized boosted model
(GBM) (Zhu et al., 2015; Fong et al., 2018). GBM fits a general model of the form,
𝑇𝑇 = 𝑚𝑚(𝑿𝑿) + 𝜀𝜀

(3.10)

where 𝜀𝜀 ~ 𝑁𝑁(0, 𝜎𝜎 2 ) and 𝑚𝑚(𝑿𝑿) is the mean function of 𝑇𝑇 given 𝑿𝑿 (Zhu et al., 2015). The

mean function is estimated using a boosting algorithm that additively fits regression trees
until the model is sufficiently flexible to fit the data (McCaffrey et al., 2013; Zhu et al.,
2015). With the mean function derived, stabilized IPWs can be calculated and implemented
just as in the MLE weighting procedure. Although it may appear as though GBM ultimately
provides minimally biased causal inference estimates, there are still drawbacks that limit its
usefulness. First, GBM does not afford users the ability to force variables into the final
treatment model (Ridgeway et al., 2016), which is often appropriate in biomedical research
(for example, age, gender, and other demographic or baseline clinical information).
Additionally, although GBM has been shown to outperform MLE in simulation studies,
covariate balance after GBM weighting can still remain poor, subsequently resulting in more
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unstable estimates than if weights were not applied at all (Fong et al., 2018). Finally, the
primary way to improve balance using GBM is by increasing the number of regression trees
used by the method, which may not provide adequate control over sample imbalance (Fong
et al., 2018).
Recent important extensions of the “covariate balancing propensity score,” which
models treatment assignment while optimizing covariate balance, have been made for
continuous treatments (Imai and Ratkovic, 2014; Fong et al., 2018). Specifically, the new
covariate balancing generalized propensity score (CBGPS) uses the method of moments
framework to derive IPWs such that the weighted correlation between 𝑿𝑿 and 𝑇𝑇 is minimized
(Fong et al., 2018). The nonparametric extension of this CBGPS (npCBGPS) places no
parametric restrictions on the GPS, as weights are directly derived without giving a
functional form to the propensity scores.
Although the CBGPS is a method for optimizing covariate balance while estimating
the GPS, it is not without limitations as shown in Fong et al. (2018). In simulation, it was
shown that GBM produces less biased causal estimates compared to CBGPS and npCBGPS
when sample sizes are large (~1,000). Additionally, since the nonparametric extension,
npCBGPS, is based on an empirical likelihood approach, there is no guarantee that the
optimization procedures find the global optimum. Furthermore, when the number of
covariates is large, or if 𝑿𝑿 strongly predicts 𝑇𝑇, the npCBGPS may fail to find a solution,

leaving the investigator to sacrifice covariate balance to derive weights. Moreover, even in
scenarios where the CBGPS and npCBGPS methods produce the best covariate balance, they
may not produce causal inference estimates with the lowest bias.
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In sum, current methods for creating balanced data in the continuous treatment setting
have relied heavily on weighting procedures, even though it has been well-studied that
weighting methods may produce unreliable causal inference estimates due to extreme
weights (Zhu et al., 2015; Fong et al., 2018). And although nonparametric methods have
been proposed to derive weights in order to attenuate this issue, it is has not yet been resolved
(Zhu et al., 2015; Fong et al., 2018). Specifically, researchers have shown within simulations
that when both treatment and outcome models are misspecified, all weighting propensity
score methods fail to obtain accurate ATE estimates (Fong et al., 2018). The current
literature indicates alternatives to weighting are desirable in some settings. Currently, fitting
� 𝑿𝑿𝑖𝑖 , that is
a parametric linear model and stratifying subjects based on the scalar value 𝜷𝜷

derived from the estimated model (Imai and Van Dyk, 2004), is the only, and seldom used
(Elliott, Zhang, and Small, 2015), stratification method proposed to produce causal estimates
for a continuous treatment. Although it is possible to successfully group subjects in this
� 𝑿𝑿𝑖𝑖 presenting with
manner, there exists a possibility of subjects with similar values for 𝜷𝜷

different covariate distributions. Therefore, this paper seeks to derive more refined methods
of stratification that neither utilize weighting nor rely on parametric assumptions in order to
produce more reliable causal inference estimates (i.e., ATEs). Specifically, the current paper
proposes two novel methodologies that produce causal estimates for continuous treatments:
both the generalized propensity score cumulative distribution function (GPS-CDF) and the
nonparametric GPS-CDF (npGPS-CDF) methods stratify subjects, based on pretreatment
confounders, in order to produce causal estimates.
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3.2 Methods
Stratifying subjects with the objective of achieving covariate balance based on
pretreatment confounders amounts to creating groups of subjects with similar covariate
distributions who received different treatments. With this goal in mind, this section describes
two novel stratification methods that seek to refine current methods in order to produce better
covariate balance and more accurate ATE estimates. Both proposed methods create subject
specific covariate distributions that are used in order to create balancing strata. The first
method (GPS-CDF) closely follows the stratification method introduced by Imai and Van
Dyk (2004). The second method (npGPS-CDF) does not place any parametric restrictions on
the relationship between 𝑇𝑇 and 𝑿𝑿.
3.2.1 GPS-CDF - parametric approach
Similar to the method proposed by Imai and Van Dyk (2004), the GPS-CDF approach
creates balancing strata from a regression model in order to produce ATE estimates.
However, to improve balance, a representation of the distribution of an individual’s
covariates is proposed, rather than using just the observed instance. This distribution, which
is derived through bootstrapping, provides more detailed covariate information for each
subject, which can lead to more accurate balancing strata and more accurate causal estimates.
The bootstrapping algorithm of the GPS-CDF method begins by fitting any regression
model in the form of equation (3.1), that returns model estimates, in order to predict the
continuous treatment (e.g. linear model, generalized linear model). 𝑇𝑇�𝑖𝑖 , or a subject’s

predicted treatment, is calculated by multiplying the estimated model coefficients by each
subject’s covariate profile,
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� 𝑿𝑿𝑖𝑖 .
𝑇𝑇�𝑖𝑖 = 𝜷𝜷

(3.11)

� ∗ coefficients are
To further capture the complete covariate profile of a subject, 𝐵𝐵 sets of 𝜷𝜷
resampled assuming a multivariate normal distribution,

� 1∗ , … , 𝜷𝜷
� ∗𝑏𝑏 ~𝑴𝑴𝑴𝑴𝑴𝑴�𝝁𝝁, ∑�
𝜷𝜷

𝛽𝛽̂1
𝝁𝝁 = � ⋮ �
𝛽𝛽̂𝑗𝑗

∑ =�

� �𝛽𝛽̂𝟏𝟏 �
𝑉𝑉𝑉𝑉𝑉𝑉

𝟎𝟎

⋱

(3.12)

𝟎𝟎

� �𝛽𝛽̂𝒋𝒋 �
𝑉𝑉𝑉𝑉𝑉𝑉

�

� �𝛽𝛽̂𝟏𝟏 �, … , 𝑉𝑉𝑉𝑉𝑉𝑉
� �𝛽𝛽̂𝒋𝒋 � are the estimates derived from the original
where 𝛽𝛽̂𝟏𝟏 , … , 𝛽𝛽̂𝒋𝒋 and 𝑉𝑉𝑉𝑉𝑉𝑉

treatment regression model with 𝑗𝑗 covariates for 𝑏𝑏 = 1, … , 𝐵𝐵 (an arbitrarily large number,

∗
taken in this paper to be 10,000). 𝑇𝑇�𝑖𝑖,𝑏𝑏
is then calculated for each subject using each of the 𝐵𝐵

� ∗ coefficients,
sets of sampled 𝜷𝜷

∗
� ∗𝑏𝑏 𝑿𝑿𝑖𝑖
𝑇𝑇�𝑖𝑖,𝑏𝑏
= 𝜷𝜷

(3.13)

∗
for 𝑏𝑏 = 1, … , 𝐵𝐵. Placing 𝑇𝑇�𝑖𝑖,𝑏𝑏
values in ascending order, individually for each subject, will

create bootstrapped distributions of each subject’s predicted treatment values. Each

distribution is a separate unimodal probability density function (PDF) that fully encapsulates
the covariate profile for each subject. The equation of a particular PDF is given by,
∗
∗
𝑃𝑃𝑃𝑃𝐹𝐹𝑖𝑖 = 𝑇𝑇�𝑖𝑖,(1)
, … , 𝑇𝑇�𝑖𝑖,(𝑏𝑏)

(3.14)

� , two subjects
for individual 𝑖𝑖. As subject specific PDFs are derived through variation in 𝜷𝜷

with identical covariate profiles will have identical PDFs; this would not be true if variation
were introduced in relation to 𝑿𝑿. Therefore, subjects with similar PDFs will have, on

average, similar covariate distributions. Thus, a function that accurately maps the PDF of
each subject can subsequently be used to classify subjects into covariate balancing strata.
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Unfortunately, mapping directly to this PDF is challenging. A PDF is not a monotone
function; the shape of the PDF depends on the covariate distribution for each subject. Instead
of mapping a function directly to the PDF, an empirical cumulative density function (eCDF)
is estimated for each subject by summing across the subject specific PDF,
𝑏𝑏

𝐹𝐹�𝑖𝑖,𝑏𝑏 (𝑡𝑡𝑖𝑖 ) = 𝑃𝑃�𝑖𝑖,𝑏𝑏 �𝑇𝑇�𝑖𝑖∗ < 𝑡𝑡𝑖𝑖 � = 𝑏𝑏 −1 �

𝑙𝑙=1

𝐼𝐼�𝑡𝑡𝑖𝑖,𝑙𝑙 ≤ 𝑡𝑡𝑖𝑖 �

(3.15)

where 𝐼𝐼 is the indicator function. The shape of the eCDF for each subject is a strictly non-

decreasing function. Furthermore, as the eCDF is a 1-to-1 function of the PDF, subjects with
similar eCDFs will have similar PDFs, and resultantly, similar covariate distributions. One
� ∗𝑖𝑖 )
proposed equation used to map the eCDF of subject specific predicted treatments (𝑻𝑻

generated from this bootstrapping method is a 2-parameter logistic curve given by,
𝐹𝐹�𝑇𝑇�� =

1

1 + exp �−𝑘𝑘 ∗ �𝑇𝑇� − 𝑇𝑇0 ��

(3.16)

where 𝑘𝑘 represents the scale or shape parameter of the logistic curve, and 𝑇𝑇0 is the location or
midpoint of the sigmoid. Once eCDFs are calculated for each subject, a non-linear least
squares (NLS) algorithm (Marquardt, 1963) is used to fit the logistic curve,
𝐵𝐵

min �
𝑘𝑘,𝑇𝑇0

𝑏𝑏=1

2

�𝐹𝐹�𝑇𝑇�� − 𝐹𝐹�𝑏𝑏 (𝑡𝑡)�

for 𝑏𝑏 = 1, . . . , 𝐵𝐵.

(3.17)

The above NLS algorithm iteratively fits values for 𝑘𝑘 and 𝑇𝑇0 until the residual distance

between the eCDF and fitted logistic curve is minimized. Based on the fitted logistic curve,
subjects with similar values for 𝑘𝑘 and 𝑇𝑇0 will have similar eCDF vectors and thus similar

covariate distributions. Although there are many ways to classify subjects into strata based on
two variables, k-Means clustering (KMC) has been shown to provide the highest covariate
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similarity within clusters (Tu, Jiao, and Koh, 2013). Additionally, while any number of strata
can be formed, following the convention set within binary treatment propensity score
analyses, 5 strata are created (Cochran, 1968; Rosenbaum and Rubin, 1984; Zanutto, Lu, and
Hornik, 2005; Austin, 2011). Thus using KMC, subjects can be accurately placed into one of
five strata with subjects with similar values for both 𝑘𝑘 and 𝑇𝑇0 , and subsequently similar
covariate distributions.

3.2.2 npGPS-CDF - nonparametric approach
Although typical propensity scoring methods fit a treatment model in order to create
covariate balance, this is not always beneficial or necessary in the continuous treatment
setting. Unlike binary and multiple treatment settings where the GPS is typically estimated
through a logistic, multinomial, or probit regression model, the continuous treatment setting
typically utilizes a linear model to calculate a predicted treatment. Thus if model assumptions
are not met (e.g., deviations from normality of errors), the predicted treatment value from the
linear model will be inaccurate, which could lead to poor balance and poor ATE estimates.
Instead, as every subject represents a unique treatment group in the continuous treatment
setting, creating balance utilizing stratification reduces to grouping subjects with similar
covariate distributions, independent of treatment assignment. Thus, a method that stratifies
subjects directly using potential confounders without using predicted treatment may improve
covariate balance.
Consider the extreme case where one has a non-randomized study with an outcome, a
continuous treatment, and two binary potential confounders (sex (male, female), and age
(<50 or ≥50)). Instead of fitting a model between treatment and the confounders, four strata
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can intuitively be created: young males, young females, older males, and older females.
Thus, without fitting a treatment model, the two confounders of interest are completely
balanced within the four strata. Although this method of stratification may not be possible in
applied contexts that include continuous confounders, it does illustrate that balancing strata
can be created without fitting a treatment model.
Utilizing the extreme case as a heuristic, the nonparametric extension to the GPSCDF method, the npGPS-CDF, does not place any parametric restrictions on the relationship
between 𝑇𝑇 and 𝑿𝑿 as it does not involve fitting a regression model for treatment. Instead, an

eCDF based solely on the potential confounders of interest is calculated for each subject and
used for stratification.
A covariate based distribution can be formed for each subject by sampling 𝐵𝐵 sets of

� ∗ values assuming any continuous distribution centered at 0 (e.g. multivariate standard
𝜞𝜞
normal, multivariate T)

�1∗ , … , 𝜞𝜞
� ∗𝑏𝑏 ~𝑴𝑴𝑴𝑴𝑴𝑴�𝟎𝟎𝑗𝑗 , I𝑗𝑗 �
𝜞𝜞

(3.18)

where 𝑗𝑗 is the number of covariates and I𝑗𝑗 is the identity matrix for 𝑏𝑏 = 1, … , 𝐵𝐵 (an

� ∗ values are then used in order to
arbitrarily large number, taken here to be 10,000). These 𝜞𝜞

� ∗ coefficients
derive subject specific covariate distributions. Each of the 𝐵𝐵 sets of sampled 𝜞𝜞

∗
is used to calculate 𝑍𝑍̂𝑖𝑖,𝑏𝑏
for each subject using,

∗
� ∗𝑏𝑏 𝑿𝑿𝑖𝑖
𝑍𝑍̂𝑖𝑖,𝑏𝑏
= 𝜞𝜞

(3.19)

∗
for 𝑏𝑏 = 1, … , 𝐵𝐵. Placing 𝑍𝑍̂𝑖𝑖,𝑏𝑏
values in ascending order, individually for each subject, will

create separate covariate distributions for each subject. The sampled distribution is given by,
∗
∗
𝑃𝑃𝑃𝑃𝐹𝐹𝑖𝑖 = 𝑍𝑍̂𝑖𝑖,(1)
, … , 𝑍𝑍̂𝑖𝑖,(𝑏𝑏)
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(3.20)

for the 𝑖𝑖 𝑡𝑡ℎ individual, which again can be thought of as a unimodal PDF. Once again, eCDFs
can be estimated for each subject by summing across subject-specific PDFs,
𝑏𝑏

𝐹𝐹�𝑖𝑖,𝑏𝑏 (𝑧𝑧𝑖𝑖 ) = 𝑃𝑃�𝑖𝑖,𝑏𝑏 �𝑍𝑍̂𝑖𝑖∗ < 𝑧𝑧𝑖𝑖 � = 𝑏𝑏 −1 �

𝑙𝑙=1

where 𝐼𝐼 is the indicator function.

𝐼𝐼�𝑧𝑧𝑖𝑖,𝑙𝑙 ≤ 𝑧𝑧𝑖𝑖 �

(3.21)

Unlike the parametric GPS-CDF method that requires a location parameter (𝑇𝑇0 ) to

accurately map each eCDF, in the nonparametric setting, all eCDFs are centered at 0. This is
� ∗ values from a continuous distribution centered at 0 (e.g.
a direct byproduct of sampling 𝜞𝜞

𝑴𝑴𝑴𝑴𝑵𝑵�𝟎𝟎𝑗𝑗 , I𝑗𝑗 � distribution). The proposed 1-parameter logistic curve that can accurately map
the eCDF of each subject is given by,

𝐹𝐹�𝑍𝑍̂� =

1
1 + exp�−𝑘𝑘 ∗ 𝑍𝑍̂�

(3.22)

where 𝑘𝑘 represents the scale or shape parameter of the logistic curve. Similarly, once the

eCDF has been calculated for each subject, an NLS algorithm (Marquardt, 1963) can be used
to fit this 1-paramater logistic curve,
𝐵𝐵

min �
𝑘𝑘

𝑏𝑏=1

�𝐹𝐹�𝑍𝑍̂� − 𝐹𝐹�𝑏𝑏 (𝑧𝑧)�

2

for 𝑏𝑏 = 1, . . . , 𝐵𝐵.

(3.23)

Importantly, the npGPS-CDF method results in a single scalar value, 𝑘𝑘, that fully

describes the covariate distribution of each subject. This single scalar balancing score can
then be used to stratify subjects into quintiles, such that subjects within a quintile will have
similar values of 𝑘𝑘 and thus similar covariate distributions.
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3.3 Simulation Study
A simulation study is conducted to determine how the GPS-CDF stratification and
npGPS-CDF stratification methods perform under different data scenarios with varying
levels of model misspecification. The design of the current simulation follows very closely to
several recently published simulations that strive to represent real data (Austin, Grootendorst,
and Anderson, 2007; Fong et al., 2018; Greene, 2017). Four data scenarios are considered
with one continuous treatment, one binary outcome, and nine baseline covariates, 4 of which
are defined as pretreatment confounders of the treatment outcome relationship. A table
describing the associations of the baseline covariates with the treatment and the outcome
variables is shown in Table 3.1. From the table, it may be noted that 𝑥𝑥1 , 𝑥𝑥2 , 𝑥𝑥4 , and 𝑥𝑥5 are

simulated to be pretreatment confounders.

The four data scenarios considered within this simulation are very similar to those of
Fong et al. (2018) and Greene (2017) in that they vary whether treatment assignment or
outcome assignment were correctly specified through inclusion of a non-linear term. Within
all four data scenarios, 𝑥𝑥1 , 𝑥𝑥6 , 𝑥𝑥8 , and 𝑥𝑥9 are multivariate normally distributed with mean 0,

variance 1, and covariances of 0.1, while all other baseline covariates (𝑥𝑥2 , 𝑥𝑥3 , 𝑥𝑥4 , 𝑥𝑥5 , and 𝑥𝑥7 )
were independently drawn from a Bernoulli(𝑝𝑝 = 0.5) distribution.

In Scenario 1, both the treatment and outcome models are correctly specified,

containing only linear terms. The true treatment and outcome models are given by equations
(3.24) and (3.25), respectively:
𝑇𝑇𝑖𝑖 = 0.6�𝑥𝑥𝑖𝑖,1 + 𝑥𝑥𝑖𝑖,4 + 𝑥𝑥𝑖𝑖,7 � + 0.2�𝑥𝑥𝑖𝑖,2 + 𝑥𝑥𝑖𝑖,5 + 𝑥𝑥𝑖𝑖,8 � + 𝜀𝜀𝑖𝑖

𝑃𝑃𝑃𝑃(𝑌𝑌 =1)

log �1−𝑃𝑃𝑃𝑃(𝑌𝑌𝑖𝑖 =1)� = 𝛼𝛼 + 0.7𝑇𝑇𝑖𝑖 + 0.6�𝑥𝑥𝑖𝑖,1 + 𝑥𝑥𝑖𝑖,2 + 𝑥𝑥𝑖𝑖,3 � + 0.2�𝑥𝑥𝑖𝑖,4 + 𝑥𝑥𝑖𝑖,5 + 𝑥𝑥𝑖𝑖,6 �
𝑖𝑖
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(3.24)
(3.25)

𝑖𝑖𝑖𝑖𝑖𝑖
where|𝜀𝜀𝑖𝑖 ~
𝑁𝑁(0,1) is the error term, 𝛼𝛼 = -5, and the true ATE is set at 0.7. The binary

outcome is simulated by sampling one value from a Bernoulli distribution using the
probabilities calculated from equation (3.25) as the probability sampling weights.
Scenario 2 introduces a non-linear term based on a mis-measured variable,

(𝑥𝑥𝑖𝑖,1 + 0.5)2 , into the treatment assignment model, while the outcome model remained the
same as equation (3.25). The misspecified treatment model is given by:
2

𝑇𝑇𝑖𝑖 = 0.4�𝑥𝑥𝑖𝑖,1 + .5� + 0.6�𝑥𝑥𝑖𝑖,1 + 𝑥𝑥𝑖𝑖,4 + 𝑥𝑥𝑖𝑖,7 � + 0.2�𝑥𝑥𝑖𝑖,2 + 𝑥𝑥𝑖𝑖,5 + 𝑥𝑥𝑖𝑖,8 � + 𝜀𝜀𝑖𝑖

(3.26)

𝑖𝑖𝑖𝑖𝑖𝑖
where|𝜀𝜀𝑖𝑖 ~
𝑁𝑁(0,1).

Scenario 3 introduces a non-linear term based on a mis-measured variable,

(𝑥𝑥𝑖𝑖,1 + 0.5)2 , into the outcome assignment model, while the treatment model remained the

same as equation (3.24). The misspecified outcome model is given by:
log �

𝑃𝑃𝑃𝑃(𝑌𝑌𝑖𝑖 = 1)
2
� = 𝛼𝛼 + 0.2�𝑥𝑥𝑖𝑖,1 + .5� + 0.7𝑇𝑇𝑖𝑖 + 0.6�𝑥𝑥𝑖𝑖,1 + 𝑥𝑥𝑖𝑖,2 + 𝑥𝑥𝑖𝑖,3 � + 0.2�𝑥𝑥𝑖𝑖,4 + 𝑥𝑥𝑖𝑖,5 + 𝑥𝑥𝑖𝑖,6 �
1 − 𝑃𝑃𝑃𝑃(𝑌𝑌𝑖𝑖 = 1)

(3.27)

where 𝛼𝛼 = -5.

Finally in Scenario 4, both the treatment and outcome models are misspecified using

the treatment and outcome assignment models detailed in equations (3.26) and (3.27) with
𝛼𝛼 = -6.
3.4 Results
For each scenario, 1000 datasets each containing 1000 observations are generated.
Five methods from the literature are applied to estimate and compare ATEs: GBM weighting,
� 𝑿𝑿𝑖𝑖 stratification, GPS-CDF stratification, and npGPS-CDF
CBGPS weighting, 𝜷𝜷

stratification. The propensity model for each method includes all 9 baseline covariates.
Outcome analyses to produce ATE estimates utilize survey-weighted generalized linear
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� 𝑿𝑿𝑖𝑖 stratification, GPSmodels for GBM and CBGPS and conditional logistic regression for 𝜷𝜷
CDF stratification, and npGPS-CDF stratification. Furthermore, to ensure robust ATE

estimates, the outcome models additionally adjusted for all first order covariates associated
with outcome assignment (Rosenbaum and Rubin, 1984; Hirano and Imbens, 2001; Imai and
Van Dyk, 2004).
Figure 3.1 is a graphical representation of covariate balance achieved by each
propensity score method under the correctly specified and incorrectly specified treatment
assignment models. The plots depict the distribution of F-statistics obtained from regressing
𝑇𝑇 on 𝑿𝑿, in the overall (unweighted) dataset and using the weights or strata derived from each
propensity score method, to give an overall covariate balance summary for the simulated
datasets (e.g., as done in Fong et al., 2018). F-statistics were calculated using weighted
generalized linear models for GBM and CBGPS. Stratified models, that pooled F-statistics
� 𝑿𝑿𝒊𝒊 stratification, GPS-CDF stratification, and
via weighted averages, were used for 𝜷𝜷

npGPS-CDF stratification, as is common with stratified analyses (Rosenbaum and Rubin,

1984; Huang et al., 2005; Austin, 2011). Methods that achieved covariate balance have Fstatistics closer to zero.
All methods compared achieve better balance, on average, compared to the original
(unweighted) data. However, weights derived through GBM produce variable F-statistics,
especially within the incorrectly specified treatment model (right plot). The balance achieved
by CBGPS weighting is better compared to GBM weighting, but CBGPS is still prone to
� 𝑿𝑿𝑖𝑖
inadequate covariate balance in both treatment assignment scenarios. Alternatively, 𝜷𝜷
stratification and GPS-CDF stratification produce smaller F-statistics, which are less

sensitive to model misspecification and less susceptible to F-statistic outliers, compared to
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both GBM and CBGPS weighting. The balance achieved by npGPS-CDF stratification
appears to be poorer overall in the correctly specified model, but better in the incorrectly
specified model, compared to GBM and CBGPS weighting. Additionally, npGPS-CDF
stratification produces F-statistics without outliers that are less sensitive to model
misspecification.
Within each scenario, the five propensity score methods are compared via average
bias, mean squared error (MSE), and coverage probability of the estimated ATE. Figure 3.2
depicts the distribution of the ATE for each method under each scenario. The true ATE value
is 0.7 and is included as the dotted horizontal line.
In Scenario 1, both GBM and CBGPS produce estimates with increased bias and
� 𝑿𝑿𝑖𝑖 stratification, GPS-CDF
MSE, as well as decreased coverage probability compared to 𝜷𝜷

stratification, and npGPS-CDF stratification. Additionally, GBM and CBGPS both produce
severe ATE outliers, which was expected as the balance produced by these methods was not
well controlled. Alternatively, even though the degree of balance produced by npGPS-CDF
stratification is poorer than other methods, it performs the best in terms of bias in ATEs and
produces the lowest MSE. When the treatment model is misspecified but the outcome model
is correct (Figure 3.2, Scenario 2), results are similar to Scenario 1. Again, GBM produces
the highest bias and MSE, and the lowest coverage probability. Although CBGPS produces
the lowest bias among the five methods, it still produces high MSE and large ATE outliers.
� 𝑿𝑿𝑖𝑖 stratification in terms of bias, MSE, and
Again, npGPS-CDF stratification outperforms 𝜷𝜷
coverage probability.

When the treatment model is correct, but the outcome model is misspecified (Figure
3.2, Scenario 3), application of GBM results in lower bias and MSE compared to CBGPS.
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Consistent with the previous scenarios, CBGPS produces large ATE outliers. GPS-CDF
stratification and npGPS-CDF stratification have lower bias and MSE compared to all other
methods, with npGPS-CDF stratification producing the most accurate estimates. Finally,
Figure 3.2 Scenario 4 further demonstrates that the weighting procedures, GBM and CBGPS,
do not perform as well compared to the stratification procedures while the novel npGPS-CDF
stratification vastly outperformed all other propensity score methods yet still maintaining a
coverage probability equal to 0.95.
For completeness, npCBGPS weighting was additionally conducted under each
simulation scenario, but the results obtained were worse than those for CBGPS weighting
under all scenarios and are therefore not presented.

3.5 Data Application: Effect of exposure to smoking imagery on smoking initiation in
youth
To assess the utility of the novel continuous propensity scoring techniques, GPS-CDF
stratification and npGPS-CDF stratification are applied to the Mexican-American Tobacco
use in Children (MATCh) study to determine whether exposure to smoking imagery in
movies influences smoking initiation among Mexican-American adolescents (Wilkinson et
al., 2008).
The MATCh study was a longitudinal population-based cohort study among
Mexican-American teens in Houston, Texas, that aimed to measure factors that influence an
adolescent’s decision to experiment with cigarettes (Spelman et al., 2009). One of the
predictors of interest, exposure to smoking imagery in movies (SIM), was measured using a
previously validated method in which subjects indicate whether or not they had viewed 50

85

randomly selected movies from a pool of 250. A scaled continuous variable which quantifies
a subject’s exposure to SIM was then calculated (Sargent et al., 2008).
Typically, the continuous SIM exposure variable is categorized into four ordinal
exposure groups. A previous ordinal propensity score analysis of these data determined that
the odds of smoking initiation among teens significantly increased as their level of exposure
to smoking imagery quartile increased (stratified ordinal propensity score OR=1.53, 95% CI
[1.15, 2.03], p= 0.004) (Greene, 2017). Although this method of categorization is not
inappropriate, categorization of a continuous treatment variable may lead to loss of
information during the outcome analysis (Zhu et al., 2015; Fong et al., 2018). The GPS-CDF
stratification and npGPS-CDF stratification methods allow one to treat SIM exposure as a
continuous covariate to assess its relationship with smoking initiation in adolescents.
Several potential pre-exposure confounders (that are associated with both the level of
exposure to smoking imagery in movies and smoking initiation) are included in the current
analyses (Table 3.2). Details of all variables included in the propensity models can be found
in previous publications (Wilkinson et al., 2009; Greene, 2017). A visual representation of
covariate balance is shown in Figure 3.3. The left plot shows the absolute Pearson
correlations between each potential confounder (including square terms) and the treatment
variable in the original (Unweighted) dataset as well as after utilization of each propensity
score method (Zhu et al., 2015; Fong et al., 2018; Austin, 2018b). Zhu et al. (2015) suggest
that correlation values less than 0.1 indicate that the confounding effect of the covariate is
small. Based on this cutoff, all propensity score methods create better covariate balance
compared to the original data.
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The right plot of Figure 3.3 presents F-statistics that are calculated by regressing the
continuous treatment variable against each potential confounder one at a time. The
interquartile range of F-statistics within the figure are (2.52-20.08) for the original data,
� 𝑿𝑿𝑖𝑖 stratification, (0.39-0.92)
(0.02-0.54) for GBM, (0.00-0.00) for CBGPS, (0.31-0.79) for 𝜷𝜷

for GPS-CDF stratification, and (0.75-2.21) for npGPS-CDF stratification. As all propensity

score methods produce small F-statistics, they result in much better balance compared to the
original data.
After stratification using GPS-CDF and npGPS-CDF, covariate imbalance within the
sample is largely removed. As our simulations show GPS-CDF and npGPS-CDF perform the
best in terms of ATE estimation, even in the presence of model misspecification, analyses of
the MATCh study are conducted using GPS-CDF and npGPS-CDF stratification. Results
from the analyses are shown in Table 3.2. The methods show that the odds of smoking
initiation among teens significantly increases as exposure to smoking imagery in movies
increases (ORGPS-CDF = 3.75, 95% CI [1.50, 9.38], p = 0.005; ORnpGPS-CDF = 3.84, 95% CI
[1.52, 9.68], p = 0.004).
� 𝑿𝑿𝑖𝑖
Results are similar when the analysis are conducted using GBM, CBGPS, and 𝜷𝜷

stratification with ORs equal to 4.41, 4.46, and 3.34, respectively. All methods attenuated the
relationship between exposure to smoking imagery in movies and the odds of smoking
initiation among teens compared to the original unweighted data (OR= 6.57). Again,
outcome analyses are conducted using survey-weighted generalized linear models and
conditional logistic regression for weighting methods and stratification methods,
respectively. Running the analyses using a dual-core Intel Core i3-3110M with 4 GB RAM,
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results were available in 28 seconds, 5 seconds, 3 seconds, 8 seconds, and 7 seconds using
� 𝑿𝑿𝑖𝑖 stratification, GPS-CDF, and npGPS-CDF, respectively.
GBM, CBGPS, 𝜷𝜷
3.6 Discussion
Although weighting methods have been proposed to conduct propensity score
analyses with continuous treatments (Robins et al., 2000; Zhu et al., 2015; Fong et al., 2018),
these methods are not always stable and may produce unreliable estimates. Through
simulation, Fong et al. (2018) showed that MLE (Robins et al., 2000) and GBM (Zhu et al.,
2015) weights may result in worse covariate balance than had no adjustment been made.
These authors further demonstrated that their newly developed weighting methods, CBGPS
and npCBGPS, were able to produce better balance than both the MLE and GBM methods.
Although the CBGPS methods aim to optimize covariate balance, this increased balance does
not always provide more accurate estimates within the outcome analyses. When both
treatment and outcome models were misspecified, they found that all weighting propensity
score methods failed to obtain accurate ATE estimates. Although, a simplistic method has
been proposed that operates without weighting, stratification based on the scalar value
� 𝑿𝑿𝑖𝑖 (Imai and Van Dyk, 2004), its performance has not been sufficiently evaluated through
𝜷𝜷
simulation, and is therefore seldom used in practice (Elliott et al., 2015). Based on the

inability of weighting procedures to produce both stable and accurate ATE estimates and the
underutilization of stratification methods for continuous treatments, we developed new
continuous propensity score stratification techniques, GPS-CDF and npGPS-CDF, and
investigated their performance against other continuous treatment propensity score methods.
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Our simulation study is stronger than some previously conducted (Austin, 2018a;
Fong et al., 2018), as it was representative of biomedical data through inclusion of both
continuous and binary covariates. The inability of GBM weighting to produce reliable and
accurate covariate balance was re-established within our simulation. When treatment
assignment was both correctly and incorrectly specified, GBM weighting produced poor
balance with patterns similar to the previous simulation (Fong et al., 2018). Unlike Fong et
al. (2018), the CBGPS method did not optimize balance for all datasets within our
simulation. Since CBGPS methods seek to minimize the weighted correlation between
baseline covariates and the treatment, inclusion of binary covariates (as with our simulation)
in the propensity score model may cause the CBGPS methods to fail, in terms of producing
reliable covariate balance. Of note, we were able to fully replicate the results of Fong et al.
(2018) using a simulation consisting of only continuous covariates (not presented), which in
our opinion, is not generally applicable to biomedical research questions.
Failure to achieve covariate balance when presented with both continuous and binary
� 𝑿𝑿𝑖𝑖 and GPS-CDF.
pretreatment confounders did not arise in the stratification methods, 𝜷𝜷

Both methods produced better balance than GBM and CBGPS within our simulation.

Interestingly, GPS-CDF stratification produced better covariate balance than npGPS-CDF
stratification. Rubin (2006) detailed, within a binary treatment setting, that matching on a
regression based scalar value produces better covariate balance than methods that match
directly on covariates. As GPS-CDF stratification is implemented using a regression model
and npGPS-CDF stratification balances directly on potential confounders, our findings in a
continuous treatment setting are analogous to those of Rubin (2006).
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GPS-CDF and npGPS-CDF stratification performed well across Scenarios 1-3 for
comparisons of the ATE. Similar to the previous simulation (Fong et al., 2018), CBGPS had
the lowest average bias among all five methods in Scenario 2 even though the balance
achieved by CBGPS weighting was worse than both GPS-CDF and npGPS-CDF, for the
incorrectly specified treatment model. This finding may further demonstrate that better
covariate balance does not always lead to less biased causal inference estimates (Lee,
Lessler, and Stuart, 2010; Stuart, Lee, and Leacy, 2013). The superiority of CBGPS
weighting within Scenario 2 did not extend outside of average bias, as CBGPS had MSE
three times that of npGPS-CDF stratification. For Scenario 4, which contained
misspecification in both the treatment and outcome models, GBM and CBGPS failed to
obtain satisfactory ATE estimates, while our newly developed GPS-CDF methods were still
robust. The npGPS-CDF method had minimal bias and MSE, and high coverage probability
for models with high amounts of misspecification.
The utility and performance of the GPS-CDF methods was further demonstrated on
the MATCh study. Our newly derived methods have similar computational burden as current
methods. Additionally, GPS-CDF and npGPS-CDF stratification produced better covariate
balance compared to the original (unweighted) dataset. Furthermore, our stratification
methods showed a stronger association between the odds of smoking initiation and exposure
to smoking imagery in movies in Mexican-American adolescents than previous ordinal
propensity score analyses (Greene, 2017). Based on these causal findings, public health
interventions, including anti-smoking ad campaigns, may be formulated and implemented to
help prevent potentially at-risk youth from forming smoking habits.
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3.7 Conclusion
This paper details the derivation and application of two propensity scoring methods
that remove imbalance due to confounding in observational studies with continuous
treatments. Unlike current methods of continuous treatment propensity scoring that utilize
weighting, the GPS-CDF and npGPS-CDF methods presented here, create balancing strata
that contain subjects with similar covariate distributions. Our simulation study shows that
stratification methods may produce less biased causal inference estimates compared to
methods that rely on weighting, since extreme weights lead to inaccurate estimates.
Furthermore, when applied to the MATCh study, the GPS-CDF and npGPS-CDF methods
found a significant association between exposure to smoking imagery in movies and smoking
initiation among Mexican-American adolescents.
There are limitations within the current study. Primarily, only 4 data scenarios were
considered within the simulation. Thus there exists a possibility that results could differ
under different modeling assumptions. However, the simulation scenarios in this paper
follow very closely to several recently published simulation studies by experts in the field of
causal inference, and are representative of real-world data (e.g., Austin et al., 2007; Fong et
al., 2018; Greene, 2017).
In summary, the novel methods presented here allow investigators additional options
when conducting continuous treatment propensity scoring in both parametric (GPS-CDF) and
nonparametric (npGPS-CDF) frameworks. As with all propensity score methods,
investigators should select the method that creates the best covariate balance for their data.
Future research should further investigate the use of stratification techniques when
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conducting continuous treatment propensity scoring with applications to relevant public
health research questions.
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Strongly Associated
with Outcome
Moderately Associated
with Outcome
Independent of
Outcome

Strongly Associated
with Treatment

Moderately Associated
with Treatment

Independent of
Treatment

𝑥𝑥1

𝑥𝑥2

𝑥𝑥3

𝑥𝑥7

𝑥𝑥8

𝑥𝑥9

𝑥𝑥4

𝑥𝑥5

𝑥𝑥6

Table 3.1. Association of covariates with treatment and outcome. From the table, it may be
noted that 𝑥𝑥1 , 𝑥𝑥2 , 𝑥𝑥4 , and 𝑥𝑥5 are simulated to be pretreatment confounders.
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Movie Exposure
Age
Gender
Born in USA
Level of Acculturation
Parental Education
Less than HS
Completed some HS
More than HS
Household Members who Smoke
None
One
Two or More
Close Peer who Smokes
Served in Detention
Cognitively Susceptibile
Risk Taking Behavior Score
POE Average
TAS
DAA
SD
SSS

ORGPS-CDF
3.75
1.25
0.73
0.92
0.75

95% CI
[1.50, 9.38]
[0.81, 1.94]
[0.36, 1.47]
[0.45, 1.86]
[0.43, 1.30]

p-value
0.005
0.307
0.378
0.811
0.298

ORnpGPS-CDF
3.84
1.34
0.72
0.99
0.78

95% CI
[1.52, 9.68]
[0.86, 2.09]
[0.42, 1.25]
[0.54, 1.82]
[0.51, 1.18]

p-value
0.004
0.196
0.248
0.969
0.241

Ref
0.96
0.67

[0.49, 1.89]
[0.30, 1.52]

0.908
0.341

Ref
1.00
0.69

[0.51, 1.96]
[0.35, 1.38]

0.996
0.295

Ref
0.81
0.71
1.40
1.39
1.09
1.17
1.41
1.00
1.38
1.30
0.92

[0.42, 1.55]
[0.26, 1.97]
[0.68, 2.87]
[0.71, 2.70]
[0.53, 2.21]
[0.78, 1.77]
[0.68, 2.91]
[0.89, 1.12]
[1.08, 1.77]
[1.05, 1.61]
[0.76, 1.12]

0.524
0.510
0.364
0.334
0.817
0.453
0.354
0.960
0.010
0.016
0.424

Ref
0.82
0.74
1.60
1.39
1.11
1.24
1.45
1.03
1.40
1.38
0.94

[0.45, 1.50]
[0.28, 1.99]
[0.80, 3.20]
[0.82, 2.38]
[0.62, 2.00]
[0.87, 1.77]
[0.75, 2.82]
[0.84, 1.28]
[1.14, 1.71]
[1.12, 1.69]
[0.72, 1.23]

0.521
0.555
0.183
0.221
0.720
0.241
0.271
0.760
0.001
0.003
0.664

Table 3.2. Model estimates after GPS-CDF and npGPS-CDF stratification from the MATCh
study. Note: HS = High School, POE = Positive outcome expectation, TAS = Thrill and
adventure seeking, DAA = Drug and alcohol, SD = Social disinhibition score, SSS =
Subjective Social Status.
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Figure 3.1. Graphical representation of the covariate balance achieved by each propensity
score method under the correctly specified and incorrectly specified treatment assignment
models. F-statistics obtained from regressing 𝑇𝑇 on 𝑿𝑿.
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Figure 3.2. Distribution of the ATE for each method under each scenario. The true ATE
value is included as the dotted horizontal line.
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Figure 3.3. Graphical representation of the covariate balance achieved by each propensity
score method within the MATCh study. The left plot presents the absolute Pearson
correlation between treatment and each potential confounder (including square terms). The
right plot presents F-statistics obtained from regressing 𝑇𝑇 on each potential confounder one
at a time.
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4.1 Introduction
A freely downloadable R software package (R Foundation, Vienna, Austria) was
created to facilitate the distribution of the newly created GPS-CDF propensity score methods.
The 𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺 R package (Brown et al., 2019) includes both the ordinal (Greene, 2017) and
multinomial (as detailed in Chapter II) GPS-CDF propensity score methods. This package
allows researchers to input a GPS vector of length >2, and outputs 𝑎𝑎�, the single scalar

balancing score that dictates the shape of the CDF. Additional functionality of the package
allows researchers to automatically match (both optimal and greedy matching) and stratify
subjects based on 𝑎𝑎�. The R documentation for the 𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺 R package (Brown et al., 2019)

is given below in Section 4.2, and an illustrative data example is detailed in Section 4.3. The
package code used to implement the GPS-CDF method is given in Appendix B.

4.2 R Documentation
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4.2.1 User Defined Inputs

4.2.2 GPS-CDF Package Outputs
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4.2.3 GPS-CDF Package Examples
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4.3 Illustrative Data Example
The methodology presented in Chapter II for estimating multiple treatments
propensity scoring is available in the 𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺 package in R (Brown et al., 2019). Below is

an illustration of how to implement the package in practice in order to estimate ATEs using
the Cerner Health Facts database (as detailed in Chapter II). This data example aimed to
analyze the relationship between vasopressor choice and mortality in patients with nontraumatic aneurysmal subarachnoid hemorrhage (SAH). We begin by loading the required
packages and reading in the SAH data.

> library(GPSCDF)
> library(twang)
> library(tableone)
> ehr<- read.csv(file="EHR_pre_treat_merged_counts.csv",
+
header=TRUE, sep=",")
> dim(ehr)
[1]

2417 275

The EHR dataset contains records for 2,417 patients with complete data for all 273
pretreatment variables (demographics and medication variables). Variables were selected for
inclusion into the GPS vector using L1-penalized generalized linear models (GLM Lasso)
(Mee Young and Hastie, 2007). This procedure was conducted in order to identify the
significant confounders associated with the choice of vasopressor treatments. After utilizing
GLM Lasso, 170 variables were selected and entered into a GBM model in order to derive
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subject specific GPS vectors. After the GPS vector is calculated for each subject, each
ordering of the GPS vector can be created.

> length(x_1)
[1]

170

> xtlm<- paste(x_1,collapse="+" )
> tmodpaste<- as.formula(paste("as.factor(VASPRESOR_Class)~",
+
xtlm, sep =""))
> #GBM model
> ps1<- mnps(tmodpaste, data=ehr, estimand="ATE",verbose =
+
FALSE, stop.method = c("es.mean"), n.trees=6000)

> #Order: 1-2-3
> pscores1<-cbind(ps1$psList$`1`$ps$es.mean.ATE,
+
ps1$psList$`2`$ps$es.mean.ATE,
+
ps1$psList$`3`$ps$es.mean.ATE)
> pscoresnorm1<- pscores1/rowSums(pscores1)
> #Order: 1-3-2
> pscores2<-cbind(ps1$psList$`1`$ps$es.mean.ATE,
+
ps1$psList$`3`$ps$es.mean.ATE,
+
ps1$psList$`2`$ps$es.mean.ATE)
> pscoresnorm2<- pscores2/rowSums(pscores2)
> #Order: 2-1-3
> pscores3<-cbind(ps1$psList$`2`$ps$es.mean.ATE,
+
ps1$psList$`1`$ps$es.mean.ATE,
+
ps1$psList$`3`$ps$es.mean.ATE)
> pscoresnorm2<- pscores2/rowSums(pscores2)
> #Order: 2-3-1
> pscores4<-cbind(ps1$psList$`2`$ps$es.mean.ATE,
+
ps1$psList$`3`$ps$es.mean.ATE,
+
ps1$psList$`1`$ps$es.mean.ATE)
> pscoresnorm4<- pscores4/rowSums(pscores4)
> #Order: 3-1-2
> pscores5<-cbind(ps1$psList$`3`$ps$es.mean.ATE,
+
ps1$psList$`1`$ps$es.mean.ATE,
+
ps1$psList$`2`$ps$es.mean.ATE)
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> pscoresnorm5<- pscores5/rowSums(pscores5)
> #Order: 3-2-1
> pscores6<-cbind(ps1$psList$`3`$ps$es.mean.ATE,
+
ps1$psList$`2`$ps$es.mean.ATE,
+
ps1$psList$`1`$ps$es.mean.ATE)
> pscoresnorm6<- pscores6/rowSums(pscores6)

4.3.1 Obtaining the Scalar Balancing Score
The function GPSCDF is called by the following, with the arguments described
below:
> gpscdf.ehr <- GPSCDF(pscores = pscoresnorm1, data = ehr,
+
trt = ehr$VASPRESOR_Class, greedy = TRUE,
+
stratify = TRUE, multinomial = TRUE)

The main argument of the GPSCDF function is pscores which indicates the ordering of
the GPS vector to be used to create 𝑎𝑎�, the single scalar balancing score that dictates the shape
of the CDF. Other key arguments include data, which indicates the name of the dataset to

attach 𝑎𝑎�; stratify, which instructs the function to create strata based on the calculated 𝑎𝑎�;
optimal and greedy, which produce either optimal or greedy matches based on 𝑎𝑎�,

respectively; ordinal and multinomial, which indicate if matches are selected from
either ordinal or multinomial treatments, respectively. The below procedure calculates 𝑎𝑎� and

additionally creates greedy matches and strata based on the GPSCDF balancing score

obtained from the initial ordering of the GPS vector. The multinomial option was specified to
ensure matches are based on the absolute difference of 𝑎𝑎�.

112

A key component of using the GPS-CDF method for multinomial treatments
propensity scoring is selecting the ordering of the GPS vector that creates the best balance in
the data. We do this by selecting the ordering that minimizes the standardized mean
difference (SMD) within matches.
> SMDdat <- gpscdf.ehr$grddata
> SMDdat$trtc <- 0
>
>
>
>
>
>
>
>
>
>
>
+
+
>
>

for(i in 1:(dim(SMDdat)[1]/2)){
matchpair<-SMDdat[which(SMDdat$grdmatch==i),]
matchpair<-matchpair[order(matchpair$VASPRESOR_Class),]
trtc<-paste(matchpair[1,4],matchpair[2,4],sep="")
SMDdat$trtc[i]<-trtc
SMDdat$trtc[i+dim(SMDdat)[1]/2]<-trtc
}
mvars=paste(x_1, sep="" )
fvars=paste(x_1[c(-1)])
MatchTab12<- CreateTableOne(vars=mvars, factorVars = fvars,
strata=c("VASPRESOR_Class"),
data=SMDdat[which(SMDdat$trtc==12),], test=F)
SMDMatch12<-abs(ExtractSmd(MatchTab12))
SMD12<-mean(SMDMatch12)

> MatchTab13<- CreateTableOne(vars=mvars, factorVars = fvars,
+
strata=c("VASPRESOR_Class"),
+
data=SMDdat[which(SMDdat$trtc==13),], test=F)
> SMDMatch13<-abs(ExtractSmd(MatchTab13))
> SMD13<-mean(SMDMatch13)
> MatchTab23<- CreateTableOne(vars=mvars, factorVars = fvars,
+
strata=c("VASPRESOR_Class"),
+
data=SMDdat[which(SMDdat$trtc==23),], test=F)
> SMDMatch23<-abs(ExtractSmd(MatchTab23))
> SMD23<-mean(SMDMatch23)
> averageSMD<-(SMD12+SMD13+SMD23)/3
> averageSMD
[1]

0.1115303
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As shown above, the overall SMD from the initial ordering of the GPS is
0.1115303. This SMD procedure is further applied to each additional ordering of the GPS

vector to determine the ordering which creates matches that minimizes the SMD among all
covariates.
> averageSMD
1-2-3
1-3-2
2-1-3
2-3-1
3-1-2
3-2-1
1 0.1115303 0.1132709 0.09815014 0.1151472 0.088769 0.1201286

Based on these results, the fifth ordering of the GPS vector (i.e. 3-1-2) produced
greedy matches which minimizes the SMD and is therefore retained for the outcome analysis.
A similar procedure can be conducted to select the ordering which minimizes SMD among
strata.
> strataSMD
1-2-3
1-3-2
2-1-3
2-3-1
3-1-2
3-2-1
1 0.1518437 0.1626902 0.1550208 0.1631293 0.1531595 0.1568014

Based on these results, the initial ordering of the GPS vector (i.e. 1-2-3) produced
strata with the minimum SMD and should be retained for outcome analyses.

4.3.2 Outcome Analyses
The orderings of the GPS vector that produce matches and strata with the best
covariate balance are retained for outcome analyses. As the outcome of interest within the
EHR dataset is mortality (i.e. a binary variable), conditional logistic regression models are
used in order to obtain ATE estimates. The below procedure is used to obtain the effect
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estimates from the greedy matched data based on the selected ordering of the GPS vector. A
similar procedure may be conducted in order to obtain ATE estimates using the selected
stratified data.

> dat <- gpscdf.ehr$grddata
> #Phenylephrine As reference
> dat$VASPRESOR_Class_2 <- relevel(as.factor(dat$VASPRESOR_Class),
+
ref = "2")
> model1<- clogit(Mortality~ as.factor(VASPRESOR_Class_2)+
+
AGE_IN_YEARS + RACE + MARITAL_STATUS + GENDER +
+
strata(grdmatch), data=dat)
> coefs1<-summary(model1)$coefficients[,1]
> secoef1<-summary(model1)$coefficients[,3]

> #Norepinephrine As reference
> dat$VASPRESOR_Class_3 <- relevel(as.factor(dat$VASPRESOR_Class),
+
ref = "3")
> model2<- clogit(Mortality~ as.factor(VASPRESOR_Class_3)+
+
AGE_IN_YEARS + RACE + MARITAL_STATUS + GENDER +
+
strata(grdmatch), data=dat)
> coefs2<-summary(model2)$coefficients[1,1]
> secoef2<-summary(model2)$coefficients[1,3]

>
>
>
>

#Dopamine vs Phenylephrine:
OR12<-exp(coefs1[1])
LCL12<-exp(coefs1[1]-qnorm(.975)*secoef1[1])
UCL12<-exp(coefs1[1]+qnorm(.975)*secoef1[1])

> OR12
as.factor(VASPRESOR_Class_2)1
1.52918
> LCL12
as.factor(VASPRESOR_Class_2)1
1.114712
> UCL12
as.factor(VASPRESOR_Class_2)1
2.097755
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>
>
>
>

#Norepinephrine vs Phenylephrine:
OR32<-exp(coefs1[2])
LCL32<-exp(coefs1[2]-qnorm(.975)*secoef1[2])
UCL32<-exp(coefs1[2]+qnorm(.975)*secoef1[2])

> OR32
as.factor(VASPRESOR_Class_2)3
1.408009
> LCL32
as.factor(VASPRESOR_Class_2)3
0.9984772
> UCL32
as.factor(VASPRESOR_Class_2)3
1.985512
>
>
>
>

#Dopamine vs Norepinephrine:
OR13<-exp(coefs2)
LCL13<-exp(coefs2-qnorm(.975)*secoef2)
UCL13<-exp(coefs2+qnorm(.975)*secoef2)

> OR13
[1] 1.086059
> LCL13
[1] 0.7911163
> UCL13
[1] 1.490961

The ATE estimates obtain above are identical to those detailed in Chapter II (Table
2.2). These results show that phenylephrine is superior to dopamine in relation to mortality in
patients with non-traumatic SAH, but the comparison between phenylephrine and
norepinephrine remains unclear.

4.4 Conclusion
The package detailed here may be freely downloaded and easily adapted for various
research projects that present with either ordinal or multinomial treatments. We have
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presented an example that shows the ease of which GPS-CDF can be applied to a large data
set, and outline key considerations when using the GPSCDF package to estimate either the
average treatment effect, or the average treatment effect among the treated.
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CHAPTER V

Conclusions and Future Work

5.1 Conclusion
Propensity score methods are used to make causal inference in non-randomized
observational studies. The goal of these methods is to create covariate balance among
treatment groups, thereby mimicking randomized control trails. Although there are countless
methods and techniques to implement propensity scoring when presented with binary
treatments, extensions to multinomial and continuous treatments are under-studied. The work
presented here fills significant gaps within the propensity score literature by introducing two
novel methodologies that remove imbalance due to confounding in observational studies with
either multinomial or continuous treatments.
As discussed in Chapter I and II, current multinomial propensity score methods do
not have the same flexibility as the scalar value derived in binary treatment settings.
Therefore, the goal of Aim 1 was to develop a novel methodology of propensity score
analysis that derives a single scalar balancing score for multinomial treatments. The proposed
method, the GPS-CDF method, accurately maps the GPS vector, produced by either
parametric or non-parametric models, to a scalar value that can be used to match or stratify
subjects. The utility of the GPS-CDF method, when presented with multinomial treatments,
was assessed via simulation and through application using an electronic health records data
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set. The flexibility and application of the GPS-CDF method provides researchers with a new
option, more relatable to standard binary propensity score techniques, when conducting
multinomial treatment propensity scoring.
Current methods for conducting propensity score analysis in the presence of
continuous treatments, as detailed in Chapter I and III, rely on weighting. Although these
methods are not inappropriate, they do not always produce accurate effect estimates due to
extreme weights. The goal of Aim 2 was to develop a novel method of propensity score
analysis for continuous treatments that does not rely on weighting. Both the GPS-CDF and
npGPS-CDF methods were derived to stratify subjects, based on pre-treatment confounders,
in order to create covariate balance in the presence of continuous treatments. Simulations as
well as an application to the MATCh data showed that these newly developed stratification
methods, GPS-CDF and npGPS-CDF, performed better than standard continuous treatment
propensity score weighting methods. Our novel methodologies allow researchers to conduct
propensity score analyses without utilizing weighting, in both parametric (GPS-CDF) and
nonparametric (npGPS-CDF) frameworks, when presented with continuous treatments.
Finally, Aim 3 provides an R package to implement the multinomial (and ordinal)
GPS-CDF method detailed in Chapter II. Although the multinomial GPS-CDF method is
straightforward to implement in practice, few researchers, especially those with noncomputational backgrounds, will take the time to implement the method for themselves.
Therefore, having a standard R package available that implements the novel GPS-CDF
method will hopefully allow more robust propensity score analyses by researchers, when
presented with multiple treatments.
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The overall strength of this research is the novelty of the proposed methods.
Currently, methods of implementing multinomial and continuous treatment propensity
scoring are not as well developed or studied as those for standard binary propensity scoring.
Aim 1 and 2 provided new multiple treatment propensity score methodologies and further
tested these novel methods in simulation. Each simulation contained multiple treatment and
outcome scenarios that were representative of real data. These detailed simulations ensure
that the methodologies developed in Aim 1 and 2 will translate well to real data applications.
Furthermore, when our novel methodologies were applied to real data applications (i.e. an
EHR data set, and the MATCh study), they out performed current standard methods in terms
of achieved covariate balance. Furthermore, the utility of any new methodology is directly
related to the ease at which it can be implemented. Therefore, the R package developed in
Aim 3 will hopefully lead researchers to use of the GPS-CDF method in practice.
There are limitations within the current work that should be acknowledged. Both
simulation studies conducted within Aim 1 and 2 only considered four different data
scenarios. Thus, the results detailed in Chapters II and III could differ under different
modeling assumptions. Additionally, the multinomial GPS-CDF method detailed in Chapter
II only utilized one non-parametric method, GBM. Therefore, it is unclear if other nonparametric methods of deriving the GPS vector will produce better balance and outcome
estimates when used in tangent with the GPS-CDF method. Finally, the continuous GPSCDF method detailed in Chapter III assumed normal distributions when bootstrapping/resampling subject specific covariate distributions. Other distributions, including the Tdistribution or non-parametric distributions, may lead to more accurate balancing strata.
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There are still many avenues for future research into propensity score methodologies
for multiple treatments. As indicated above, other non-parametric machine learning
techniques should be tested and examined to find a methodology that most accurately derives
the GPS vector for multinomial treatments. Additionally, as our method was able to
accurately derive effect estimates when presented with three treatment groups, the
multinomial GPS-CDF method may be extended to genetic applications when analyzing SNP
data. Furthermore, through our work, it appears that stratification methods may outperform
weighting methods within the continuous treatment setting. Therefore, other stratification
techniques may be derived and tested in the continuous treatment setting. For example,
stratification based on the predicted value derived from the CBGPS method may prove more
accurate than stratification based on a linear model. Overall, propensity scoring is a growing
tool for researchers to implement when working with observational data. It is up to subject
specific researchers to determine which method creates the optimal balance in their data.
Future propensity score research should continue to evaluate the merit and application of the
GPS-CDF methodologies when working with multinomial and continuous treatments.
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Appendices
Appendix A. Supplemental Figures

Supplemental Figure 1. Distribution of the ATE for each method under each scenario
between treatment 1 and treatment 2. The true ATE value of 0.7 is included as the dotted
horizontal line.
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Supplemental Figure 2. Distribution of the ATE for each method under each scenario
between treatment 2 and treatment 3. The true ATE value of -0.3 is included as the dotted
horizontal line.
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Supplemental Figure 3. Graphical representation of the CDF mapping produced by the GPSCDF method under 3, 4, 6, and 10 multinomial treatment group scenarios, respectively.
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Appendix B. Code for implementation of GPS-CDF method using R software
#####################################################
# R Function to create Generalized Propensity Score #
#
Cumulative Distribution Function (GPS-CDF)
#
#####################################################

GPSCDF<-function(pscores=NULL, data=NULL, trt=NULL, stratify=FALSE, nstrat=5,
optimal=FALSE, greedy=FALSE, ordinal=FALSE, multinomial=FALSE,
caliper=NULL){
if(is.null(stratify)){
stratify<- FALSE
}
if(is.null(optimal)){
optimal <- FALSE
}
if(is.null(greedy)){
greedy <- FALSE
}
N<-dim(pscores)[1] # Number of subjects
size<-dim(pscores)[2] # Number of treatments
cpscores<-t(apply(pscores[,], 1,cumsum))
Z<- seq(1, dim(pscores)[2], by=1)
if(sum(pscores)/N == 1){
Znorm<-sort(unique(Z))/max(unique(Z))
ppar<-rep(0,N)
for( i in 1:N){
y<-cpscores[i,]
mod<-stats::nls(y~I(Znorm^exp(power)), control = stats::nls.control(maxiter =
150, tol = 1e-05, minFactor = 1/1024,printEval = FALSE, warnOnly = TRUE),
start = list(power = 0),trace = F)
parm<-summary(mod)$coefficients[1]
mod<-stats::nls(y~I(Znorm^exp(power)), control = stats::nls.control(maxiter =
150, tol = 1e-05, minFactor = 1/1024,printEval = FALSE, warnOnly = TRUE),
start =list(power =parm),trace = F)
parm<-summary(mod)$coefficients[1]
ppar[i] <- parm
}
if (!is.null(data)){
data$a<- ppar
data2<- data
}
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#Set up Stratification
if(stratify==TRUE){
strata<-dplyr::ntile(ppar, n=nstrat)
if (!is.null(data)){
data$strata<-strata
}
} else{
strata<- NULL
nstrat<- NULL}

#Set up Optimal Matching
if(optimal==TRUE){
if (is.null(data)){
stop('Specify a dataframe to attach matches')
} else{
if (is.null(trt)){
stop('Specify a treatment variable to proceed with matching')
} else{
if (ordinal==FALSE & multinomial==FALSE){
stop('Specify Ordinal or Multinomial treatments')
} else{

# Set up matching score
epsilon=1e-5
deltamat<-matrix(0,nrow=N,ncol=N)
deltamat2<-matrix(0,nrow=N,ncol=N)
# Loops to set up delta matrix
if(ordinal==TRUE){
for(i in 1:N){
deltamat[i,]<-((ppar[i]-ppar)^2+epsilon)/((trt[i]-trt)^2)
}
}
if(multinomial==TRUE){
for(i in 1:N){
for(k in 1:N){
if(trt[i]==trt[k]){deltamat[i,k]<-999} else{
deltamat[i,k]<- abs((ppar[i]-ppar[k]))}
}
}
}

for(i in 1:N){
deltamat2[i,]<-abs((ppar[i]-ppar))
}
#Get rid of Inf and put in 999999
deltamat[!is.finite(deltamat)]<-99
diag(deltamat)<-99
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# Derigs algorithm only works with integers so we can multiply all
distances # by 10,000 to get accuracy to 4 decimal places
deltamatint<-deltamat*100000
# Use distancematrix function to reform so we can do NBP matching
suppressWarnings(distmat<-nbpMatching::distancematrix(deltamatint))
# Set up matches
invisible(utils::capture.output(matchset<nbpMatching::nonbimatch(distmat)))
#Remove row if N is odd
matches1<-matchset$halves[ grep("ghost", matchset$halves$Group2.ID,
invert = TRUE) , ]
matches<- matches1[ grep("ghost", matches1$Group1.ID, invert = TRUE) , ]
#Find distances of matches
matchmat<-matrix(NA, nrow=round(dim(matches)[1]), ncol=3)
for(i in 1:dim(matches)[1]){
pair<-matches[i,c(2,4)]
value<- deltamat2[pair[1,1],pair[1,2]]
matchmat[i,1]<-pair[1,1]
matchmat[i,2]<-pair[1,2]
matchmat[i,3]<-value
}
npairs<-dim(matchmat)[1]
#Calculate Average Total Distance of Matched Pairs
optdistance<- sum(matchmat[,3])/npairs
data$optmatch<-0
# Attach matches to data
for(i in 1:dim(data)[1]){
data$optmatch[matches[i,2]]<-i
data$optmatch[matches[i,4]]<-i
}
optmatch<-data$optmatch
}
}
}
} else{
optmatch<- NULL
optdistance<- NULL}

#Set up Greedy Matching
if(greedy==TRUE){
if (is.null(data)){
stop('Specify a dataframe to attach matches')
} else{
if (is.null(trt)){
stop('Specify a treatment variable to proceed with matching')
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} else{
if (ordinal==FALSE & multinomial==FALSE){
stop('Specify Ordinal or Multinomial treatments')
} else{
# Set up matching score
epsilon=1e-5
deltamat<-matrix(0,nrow=N,ncol=N)
deltamat2<-matrix(0,nrow=N,ncol=N)
#Set Caliper
if (is.null(caliper)){
caliper<-.25*stats::sd(ppar)
}
# Loops to set up delta matrix
if(ordinal==TRUE){
for(i in 1:N){
deltamat[i,]<-((ppar[i]-ppar)^2+epsilon)/((trt[i]-trt)^2)
}
}
if(multinomial==TRUE){
for(i in 1:N){
for(k in 1:N){
if(trt[i]==trt[k]){deltamat[i,k]<-999} else{
deltamat[i,k]<- abs((ppar[i]-ppar[k]))}
}
}
}

for(i in 1:N){
deltamat2[i,]<-abs((ppar[i]-ppar))
}
#Get rid of Inf and put in 999
deltamat[!is.finite(deltamat)]<-999
diag(deltamat)<-999
# Use Greedy matching to get matches
# Set up matches
# Set up holding for matches
matchmat<-matrix(NA, nrow=round(dim(deltamat)[1]/2), ncol=3)
#Replace matched pairs with maximum of delta matrix so it wont be used
again
repnum<-max(deltamat)
i<-0
while(min(deltamat) < caliper){
i<-i+1
inds = which(deltamat== min(deltamat), arr.ind=TRUE)
value= deltamat2[inds[1,1],inds[1,2]]
pair<-inds[1,1:2]
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matchmat[i,1:2]<-pair
matchmat[i,3]<-value
deltamat[pair,]<-repnum
deltamat[,pair]<-repnum
}
matchmat<-matchmat[is.na(matchmat[,1])==F,]
npairs<-dim(matchmat)[1]
#Calculate Average Total Distance of Matched Pairs
grdydistance<- sum(matchmat[,3])/npairs
# Attach matches to data
data2<- data2[matchmat,]
data2$grdmatch<-0
for(j in 1:(dim(data2)[1]/2)){
data2$grdmatch[j]<-j
data2$grdmatch[j+dim(data2)[1]/2]<-j
}
grdmatch<-data2$grdmatch
grddata<-data2
}
}
}
} else{
caliper<- NULL
grdmatch<- NULL
grddata<- NULL
grdydistance<-NULL}

} else{
stop('Pscores must add to 1')
}

returnlist<-list(ppar=ppar, data=data, nstrat=nstrat, strata=strata,
optmatch=optmatch, optdistance=optdistance, caliper=caliper,
grddata=grddata, grdmatch=grdmatch, grdydistance=grdydistance, NULL=NULL)
returnlistfinal<- returnlist[-which(sapply(returnlist, is.null))]
return(returnlistfinal)
}
########################
# END GPS-CDF Function #
########################
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